The QualityStocks Daily Tuesday, August 17th, 2021

Today's Top 3 Investment Newsletters

QualityStocks(VRPX) $15.3500 +265.48%

BioMedWire(CNSC) $0.4000 +60.00%

Schaeffer's(SESN) $1.5100 +23.77%

The QualityStocks Daily Stock List

Aegon N.V. (AEG)

MarketBeat, MarketClub Analysis, StocksEarning, The Online Investor, Louis Navellier, Daily Trade Alert, InvestorPlace, Marketbeat.com, Trades Of The Day, Daily Markets, SmarTrend Newsletters, INO.com Market Report, BUYINS.NET, Zacks, The Wealth Report, StreetAuthority Daily, Barchart, The Street, StreetInsider, AnotherWinningTrade, Daily Market Beat, Wealth Insider Alert, Darwin Investing Network, Money Morning, Market FN, AllPennyStocks, Navellier Growth, Stock Research Newsletter, The Best Newsletters and Wall Street Resources reported earlier on Aegon N.V. (AEG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aegon N.V. (NYSE: AEG) (OTC: AEGOF) (AMS: AGN) is a holding firm that is engaged in the provision of financial services which include asset management and pension services.

The firm has its headquarters in The Hague, the Netherlands and was incorporated in 1844. It serves consumers in Asia, Europe and the Americas.

The company operates through the Holding and Other, Asset management, International, United Kingdom, the Netherlands and the Americas segments. The asset management segment is made up of strategic partnerships and AAM Global Platforms while the International segment comprises of Portugal, Spain, Romania, Turkey, Poland, Hungary, Indonesia, India, China, Singapore and Hong Kong. The U.K. segment is involved in existing digital and business solutions while the Netherlands segment is made up of Aegon Netherlands. On the other hand, the Americas segment covers businesses in Brazil and the U.S. while the Holding segment is involved in financing activities, among others.

The enterprise provides savings products which include stable value solutions, mutual funds, annuities and retirement plan services. Its insurance products include pension products, car and household insurance, casualty and property insurance, as well as health, accident and life insurance. It also offers institutional and retail investment management solutions and digital banking services. The enterprise markets its products via advice centers, independent financial advisors, employee benefits consultants, banks, agents and brokers.

The company is planning to expand its hedging program to grow the predictability of capital generation and release capital. This move will bring in more investors into the firm, which will in turn boost the company’s growth.

Aegon N.V. (AEG), closed Tuesday's trading session at $4.87, off by 2.6%, on 2,412,024 volume with 7,102 trades. The average volume for the last 3 months is 1.76M and the stock's 52-week low/high is $2.30999994/$5.11000013.

CVD Equipment (CVV)

Wall Street Resources, MarketBeat, StreetInsider, TradersPro, CRWEFinance, Streetwise Reports, DrStockPick, Marketbeat.com, QualityStocks, PennyToBuck, CRWEPicks, CRWEWallStreet, MarketClub Analysis, PennyOmega, SmarTrend Newsletters, StockHotTips, Outsider Club, Market Wrap Daily, BestOtc, TradingMarkets, TopStockAnalysts, The Street, Street Insider, Greenbackers, Zacks, StockMarketWatch, OTC Markets Group, Barchart, SmallCapVoice and FeedBlitz reported earlier on CVD Equipment (CVV), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CVD Equipment Corporation (NASDAQ: CVV) (FRA: 0V3) is focused on designing, developing, manufacturing and selling process equipment and solutions which are utilized in the development and manufacture of coatings and materials for industrial and research applications.

The firm has its headquarters in Central Islip, New York and was incorporated in 1982, on October 13th by Leonard A. Rosenbaum. The firm serves consumers in the United States as well as internationally.

The company operates through the CVD Materials, SDC, Corporate and CVD segments. The corporate segment refers to the company’s administration activities which include anti-corrosion, customer support and process software services while the CVD materials segment provides material coatings for electronic, medical and aerospace applications. The SDC segment comprises of its ultra-high purity manufacturing division while the CVD segment is used for chemical vapor deposition equipment manufacturing. The company serves the solar photovoltaics, semiconductor, optoelectronics, nanomaterials, military, medical, glass coatings and aerospace markets.

The enterprise provides custom and standard fabricated quartz-ware used in various tools as well as its equipment. It also offers replacement and repair services for existing quartz-ware. In addition to this, the enterprise provides rapid thermal processing systems used in silicide formation. It also avails chemical vapor deposition systems which are utilized in researching, developing and manufacturing solar cells, carbon nanotubes and nanowires.

The company recently received a huge order from a major electric car battery material manufacturer in the U.S. With electric vehicle sales projected to grow significantly in the coming years, this contract will be helpful in extending the firm’s consumer reach in the sector and will also help bring in more opportunities and investments into the firm, which will have a positive effect on the company’s growth.

CVD Equipment (CVV), closed Tuesday's trading session at $5.02, off by 4.7438%, on 238,683 volume with 1,234 trades. The average volume for the last 3 months is 169,730 and the stock's 52-week low/high is $2.6400001/$7.82999992.

Evoke Pharma (EVOK)

MarketBeat, Jason Bond, Kiplinger Today, TradersPro, BUYINS.NET, StockMarketWatch, Marketbeat.com, Streetwise Reports, StreetInsider, Daily Trade Alert, TraderPower, TopPennyStockMovers, Penny Stock Prodigy, Seeking Alpha, Investing Futures, Barchart, Schaeffer's, Trades Of The Day, Short Term Wealth, Stock Market Watch, Street Insider and QualityStocks reported earlier on Evoke Pharma (EVOK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Evoke Pharma Inc. (NASDAQ: EVOK) (FRA: EV0) is a pharmaceutical firm that is engaged in the manufacture, development and commercialization of therapies that can treat gastroenterological ailments and disorders.

The firm has its headquarters in Solana Beach, California and was incorporated in January 2007 by David A. Gonyer, Scott L. Glenn, Cam L. Garner and Matthew J. D’Onofrio. The firm serves consumers in the United States.

The enterprise markets its products to select health care providers, primary care physicians, internal medicine specialists and gastroenterologists. Its product pipeline is made up of a metoclopramide nasal spray known as Gimoti, which has concluded phase 3 clinical trials testing its effectiveness in treating symptoms linked to recurrent and acute diabetic gastroparesis in females. This gastrointestinal disorder hinders the stomach from emptying its contents at the appropriate time, which results in severe digestive system symptoms. It affects millions globally. The spray formulation, which is a mixed 5-HT3 and 5-HT4 antagonist, has anti-emetic and promotility effects and has been designed to offer systemic delivery of the molecule via the nasal mucosa. Before this formulation was developed, metoclopramide was the sole drug available in the U.S. indicated for the treatment of gastroparesis. The drug was only available in intravenous and oral forms.

The company recently announced its financial results for 2021’s second quarter, with its CEO noting that they were focused on driving the company’s marketing and commercial initiatives forward and making Gimoti the preferred treatment option for diabetic gastroparesis patients, which would not only bring in investment opportunities into the firm but also extend its consumer reach, which would be good for the company’s growth.

Evoke Pharma (EVOK), closed Tuesday's trading session at $1.21, off by 9.7015%, on 1,266,043 volume with 3,239 trades. The average volume for the last 3 months is 538,241 and the stock's 52-week low/high is $1.03629994/$5.78999996.

Yamana Gold (AUY)

MarketClub Analysis, Schaeffer's, The Street, InvestorPlace, Daily Wealth, StocksEarning, StreetInsider, MarketBeat, Daily Profit, TopStockAnalysts, Streetwise Reports, Lebed.biz, Wyatt Investment Research, Marketbeat.com, Money Morning, Daily Trade Alert, TradersPro, Top Pros' Top Picks, TradingMarkets, TheStockAdvisor, Hit and Run Candle Sticks, The Online Investor, Uncommon Wisdom, Wealth Daily, SmarTrend Newsletters, The Growth Stock Wire, Energy and Capital, StreetAuthority Daily, Penny Detectives, National Inflation Association, Money and Markets, Profit Confidential, Dynamic Wealth Report, Trades Of The Day, Wall Street Greek, Zacks, ChartAdvisor, Street Insider, Forbes, InvestorGuide, PennyOmega, SmallCapInvestor.com, ProfitableTrading, TheStockAdvisors, Wealth Insider Alert, Rick Saddler, Wall Street Daily, Gold World, Flagler Financial Group, FeedBlitz, Trade of the Week, The Tycoon Report, Darwin Investing Network, The Stock Enthusiast, Wall Street Mover, Wealthpire Inc., Cabot Wealth, Bourbon and Bayonets, Trading Markets, Super Stock Investor, Pennybuster, Barchart, Outsider Club, OTC Picks, One Hot Stock, Insider Wealth Alert, SmallCapVoice, Pumps and Dumps, The Best Newsletters, Market FN, Market Authority, The Motley Fool, Kiplinger Today, The Trading Report and Seeking Alpha reported earlier on Yamana Gold (AUY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Yamana Gold Inc. (NYSE: AUY) (TSE: YRI) (FRA: RNY) is a precious metals producer that is engaged in the exploration and development of precious metals, with a focus on silver, copper and gold.

The firm has its headquarters in Toronto, Canada and was incorporated in 2003, on July 30th by Peter Marrone. Prior to its name change in August 2003, the firm was known as Yamana Resources Inc. The firm serves consumers across the globe.

The company operates through the Corporate and other, Cerro Moro, Minera Glorida, Jacobina, Canadian Malartic and El Peñón segments. It has land positions in the Americas, including in Mexico, Chile, Argentina and Brazil and is planning to build on this base via existing operating mine expansions, developing new mines, advancing its exploration properties and targeting other mineral opportunities.

The enterprise has exploration and gold development stage properties with substantial gold production. These include the Camflo, Wasamac and Minera Florida properties. Its Minera operation is an underground silver-gold mine that extracts an estimated 2300 tons of mineral-rich ore daily and is found in central Chile. Its Cerro Moro project is a silver-gold operation that is found in the Argentinian province of Santa Cruz while its Malartic project is an open pit mine found in Quebec’s Abitibi region. On the other hand, its El Penon project is an underground silver-gold mine found in northern Chile while its Jacobina operation has underground mines and is found in northeast Brazil.

The firm recently announced its operational and financial results of 2021’s second quarter which show an increase in production. This, coupled with the firm’s decision to raise its annual dividend will bring in more shareholders into the firm and boost its growth.

Yamana Gold (AUY), closed Tuesday's trading session at $4.35, off by 0.457666%, on 12,013,472 volume with 18,610 trades. The average volume for the last 3 months is 12.575M and the stock's 52-week low/high is $3.99/$6.48000001.

Accelerate Diagnostics (AXDX)

The Street, MarketBeat, Marketbeat.com, InvestorPlace, Money Morning, StreetInsider, CustomerService, Schaeffer's, TradersPro, Barchart, INO.com Market Report, Kiplinger Today, Street Insider, Agora Financial, Schaeffer’s, StreetAuthority Daily, Daily Trade Alert, Daily Market Beat, Shah's Insights & Indictments, StockMarketWatch and Trader Prep reported earlier on Accelerate Diagnostics (AXDX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Accelerate Diagnostics Inc. (NASDAQ: AXDX) (FRA: 1AB) (BMV: AXDX) is an in vitro diagnostics firm that is engaged in the provision of solutions for diagnosing severe bacterial infections.

The firm has its headquarters in Tucson, Arizona and was incorporated in 1982, on May 26th. Prior to its name change in December 2012, the firm was known as Accelr8 Technology Corp. The firm serves consumers in the Middle East, Europe and the United States, as well as the worldwide healthcare sector.

The company’s platform, the Accelerate ID/AST system, is used to determine if live fungal or bacterial cells observed in a sample are defenseless against a specific antibiotic. The system can also analyze positive blood culture samples in about 5 hours, which is faster, in comparison with conventional testing methods.

The enterprise offers a test kit for its system known as the Accelerate PhenoTest, which identifies and tests for antibiotic susceptibility in patients who may have fungemia or bacteremia, which are both life-threatening conditions with high mortality and morbidity risk. In addition to this, it provides an in vitro diagnostic platform known as the Accelerate Pheno system, which identifies and tests for antibiotic susceptibility of pathogens linked to severe healthcare-associated infections including gram-negative and gram-positive organisms.

The firm’s new IVD Accelerate PhenoTest BC kit configuration was recently CE marked and will soon be available in Europe. This move not only offers options that accommodate the different lab and clinical settings in Europe but will also extend the firm’s consumer reach, which may in turn boost its growth.

Accelerate Diagnostics (AXDX), closed Tuesday's trading session at $6.21, up 0.811688%, on 131,538 volume with 1,588 trades. The average volume for the last 3 months is 158,736 and the stock's 52-week low/high is $5.76000022/$15.7399997.

NXT Energy Solutions, Inc. (NSFDF)

QualityStocks, SmarTrend Newsletters, MarketBeat, Vantage Wire, TopPennyStockMovers, Streetwise Reports, StockOodles, SeriousTraders and PoliticsAndMyPortfolio reported earlier on NXT Energy Solutions, Inc. (NSFDF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

NXT Energy Solutions, Inc. is a technology business.  The Company’s proprietary Stress Field Detection (SFD®) survey system uses quantum-scale sensors to detect gravity field perturbations in an airborne survey method that can be used onshore and offshore to remotely identify areas with exploration potential for traps and reservoirs. Established in 1994, NXT Energy Solutions is headquartered in Calgary, Alberta.

The Company’s unique  geophysical service is for the upstream oil & gas industry.  SFD® is environmentally friendly. It is unaffected by ground security issues or difficult terrain.  SFD® is an airborne tool. It provides information on areas favorable to fluid entrapment in the sedimentary column. The SFD® survey is complementary to existing geophysical methods, especially seismic programs.

NXT Energy Solutions provides its clients with an effective and reliable method to lessen time, costs, and risks related to exploration. The  SFD® survey system allows its clients to focus their hydrocarbon exploration decisions concerning land commitments, data acquisition expenditures, and prospect prioritization on areas with the greatest potential.

SFD®, in pre-seismic applications, can produce high-potential prospect leads in large underexplored regions. In post-seismic applications, SFD® can prioritize seismic prospects based on their reservoir potentials.

The company was recently pleased to announce it is receiving advisory services and funding of up to $50,000 from the National Research Council of Canada Industrial Research Assistance Program (“NRC IRAP”) to support the research and development of the Stress Field Detection (SFD®) technology for geothermal applications. The objective of this project will be to test, identify and analyze the desired elements of the SFD® geothermal sensor response over known geothermal areas with the ultimate goal of providing a green upstream geophysical service for advancing renewable power initiatives in Canada and abroad.

NXT Energy Solutions, Inc. (NSFDF), closed Tuesday's trading session at $0.3967, up 24.8269%, on 477,000 volume with 32 trades. The average volume for the last 3 months is 13,471 and the stock's 52-week low/high is $0.230000004/$0.687900006.

Virpax Pharmaceuticals (VRPX)

MarketClub Analysis and QualityStocks reported earlier on Virpax Pharmaceuticals (VRPX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Virpax Pharmaceuticals Inc. (NASDAQ: VRPX) is a preclinical stage biopharmaceutical firm that is engaged in the development and manufacture of non-addictive and non-opioid pharmaceutical products.

The firm has its headquarters in Berwyn, Pennsylvania and was incorporated in 2017 on May 12th by Anthony P. Mack. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector, in the biotech and pharma sub-industry. The firm serves consumers in the U.S.

The company manufactures its pharmaceuticals products through the use of drug delivery systems for pain management. It has global rights to an intranasal NCE (New Chemical Entity) that delivers encephalin to the brain for the treatment of PTSD and the management of cancer pain as well as chronic pain, using its Molecular Envelope Technology.

The enterprise’s product pipeline is made up of an encephalin intranasal spray for chronic and acute pin dubbed Envelta (NES100); a formulation indicated for chronic osteoarthritis affecting the knee, known as OSF200; a bupivacaine liposomal gel indicated for the management of post-op pain dubbed LBL100 (Probudur) and a metered-dose diclofenac spray film developed to manage acute musculoskeletal pain, known as Epoladerm. In addition to this, the enterprise is involved in the development of a masking spray that decreases or prevents the intensity or the risk of viral infections like the coronavirus in people, known as MMS019; and a formulation to manage PTSD, dubbed PES200.

The company recently announced that it would be submitting an Investigational New Drug application for its Envelta formulation for chronic pain. The approval of the application by the FDA will allow human trials to begin, bringing the firm one step closer to commercialization, if the treatment proves itself to be efficacious. The treatment’s success will not only be beneficial to patients but also bring in more investors into the firm, which will be good for the company’s growth.

Virpax Pharmaceuticals (VRPX), closed Tuesday's trading session at $15.35, up 265.4762%, on 164,939,051 volume with 758,540 trades. The average volume for the last 3 months is 2.296M and the stock's 52-week low/high is $3.70000004/$16.4799995.

Two Hands Corporation (TWOH)

Penny Stock General, Shiznit Stocks, StockRockandRoll, QualityStocks, Penny Stock 101, PennyStockLocks, Penny Stock Titans, Penny Picks, Damn Good Penny Picks, Profitable Trader Authority, OTCtipReporter, PennyStockScholar, Stock Commander, Small Cap Firm, GrowthPennyStocks, Fierce Analyst, BeatPennyStocks, PennyStockProphet, StockWireNews, Penny Pick Finders, StockOnion, Monster Alerts, Buzz Stocks, Insider Financial, MicroCapDaily, MassiveStockProfits, InvestorSoup, Epic Stock Picks, HotOTC, Make Penny Stocks Great Again, Beacon Equity Research, Penny Stock Finder, Wolf of Penny Stocks, ProTrader, Stock Preacher, StockHideout, Penny Stock Craze, OTCMagic, Penny Stock 106, Penny Stock Prodigy, PennyStockLocks.com, Explicit Penny Picks, StockStreetWire, Wealth Insider Alert and Winston Small Cap reported earlier on Two Hands Corporation (TWOH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Two Hands Corporation is a top custom application development company. Its focus is on creating a complete co-parenting solution, delivering tools that enable co-parents to better collaborate about parental responsibilities, in a clear and positive way. The Company formerly went by the name Innovative Product Opportunities, Inc. It changed its name to Two Hands Corporation in September of 2016. Founded in 2009, Two Hands Corporation has its head office in Toronto, Ontario.

The Company’s "Two Hands" web application launched in July of 2018. Two Hands’ ultimate aim is to improve the lives of families affected by divorce. Two Hands states that "Two Hands" is an ideal solution that will reduce the stress and worries of co-parenting.

Concerning its other offerings, Two Hands’ Gone App enables one to send encrypted text messages right from their phone, combining military-grade security, confidentiality, and privacy – with first-rate convenience, right at their fingertips. All text messages are asymmetrically encrypted. It is safe, with keys that only the rightful user owns. Gone App features Message Auto-Deletion after being read; no preview, one must click to view the message; and Screen Capture is disabled.

Moreover, Two Hands Corp Lab is an organic hemp based CBD (cannabidiol) cultivator located in Colombia. Two Hands Corp Lab is vertically integrated, producing from seed to wholesaler. It will distribute its high grade hemp based oil primarily through Latin America and Australia. In addition, it will expand its reach once countries allow for importation.

Two Hands Corporation has diversified. This is to meet new demand for online delivery due to the current Covid-19 Pandemic. In May of this year, the Company announced it was ready to launch the GoCart brand of grocery delivery applications in early June. Its GoCart Online Grocery Delivery set of applications will be rolled out in stages to meet the growing demand for online grocery delivery.

GOCART.CITY offers farm fresh, artisanal, and specialty grocery selections, delivered right to one’s doors. Customers can easily choose their choice of fresh produce, quality cut fruits and vegetables, and a wide variety of day-to-day grocery items. According to a February 2020 report by CBC, the expectation is that online grocery delivery will grow anywhere between 5-7 percent over the next decade. That equates to almost $15 billion worth of business. GOCART.CITY services the Greater Toronto Area.

Two Hands Corporation (TWOH), closed Tuesday's trading session at $0.00415, up 25.7576%, on 229,502,279 volume with 1,060 trades. The average volume for the last 3 months is 92.159M and the stock's 52-week low/high is $0.001599999/$0.013.

CGrowth Capital (CGRA)

PennyStocks24, Penny Stocks VIP, QualityStocks, Penny Pick Insider, Daily Stock Motion, Jet-Life Penny Stocks, OTPicks, Penny Investor Network, Pumps and Dumps, PennyDoctor, InvestorPlace, Winston Small Cap, Penny Picks, Damn Good Penny Picks, OTCPicks, OTCMagic, OTC Magic, Wallstreetlivechat, Greenbackers, Penny Champions, Whisper from Wall Street, Center Stage Stocks, AllPennyStocks, AimHighProfits, InsideBulls, Otcstockexchange, TheMicrocapNews, Stock Twiter, Penny Dreamers, 007 Stock Chat, The Observer, Penny Stock Newsletter, StockRunway, Penny Trackers, Stockgoodies, PennyStockSpy, Pennystocktweeters.com, Promotion Stock Secrets and OtcWizard reported earlier on CGrowth Capital (CGRA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CGrowth Capital Inc. (OTC: CGRA) is a holding firm for assets and businesses that is focused on exploration, mineral and mining activities and also commercial real estate in the U.S.

The firm has its headquarters in Silverdale, Washington and was incorporated in 1986, on October 30th. Prior to its name change in February 2010, the firm was known as Anchor Pacific Underwriters Inc.

The enterprise’s solutions and services have been designed to help land owners monetize undervalued assets by bringing commodities like gas and oil, silver, gold and dolomite to market. It builds value via the proving of reserves and generating revenues from its many projects. The enterprise is actively engaged in evaluating opportunities in the burgeoning legalized marijuana and hemp sectors.

The company is focused on the acquisition of land assets while also offering affiliates and partners with logistical, contract management, capital and management services necessary for operation execution. This is in addition to offering processing applications and support for land owners. It owns roughly 50 acres of industrial property in Chewelah, Washington; more than 1100 acres of oil leases in Louisiana and about 3400 acres of oil leases in the Powder River Basin. Its gas and oil division Powder River Resources Inc. is an independent gas and oil exploration firm.

The firm has plans to enter into a partnership initiative with Eyecity.com Inc. which will help finance and develop a marijuana retail and industrial epicenter. If successful, the venture will bring in additional revenue as well as encourage more investors to inject funds into the firms, which will in turn boost its growth.

CGrowth Capital (CGRA), closed Tuesday's trading session at $0.019, up 36.6906%, on 28,307,517 volume with 834 trades. The average volume for the last 3 months is 1.04M and the stock's 52-week low/high is $0.003/$0.027.

ALFI Inc. (ALF)

Penny Pick Finders, Broad Street, Fierce Analyst, Mega Stock Alerts, AwesomeStocks, OTCtipReporter, StockWireNews, PennyStockProphet, PennyStockScholar, Profitable Trader Authority, StockStreetWire, QualityStocks, Small Cap Firm, StockOnion, Damn Good Penny Picks, BUYINS.NET, BeatPennyStocks and Penny Picks reported earlier on ALFI Inc. (ALF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

ALFI Inc. (NASDAQ: ALF) is an enterprise SaaS platform powered by AI that is engaged in the provision of interactive AI and machine learning software solutions.

The firm, which has its headquarters in Miami Beach, Florida, was incorporated in 2018. Before changing its name in January 2020, the firm was known as Lectrefy Inc. It serves consumers in the United States.

The enterprise utilizes big data analytics and artificial intelligence to predict and measure human responses. Its machine learning algorithms perform with high accuracy levels. Its computer vision technology, which is AI powered, is used to determine the emotion, geolocation, ethnicity, gender and age of an individual in front of a device that is Alfi-enabled, like a tablet.

The company also offers solutions that bring accountability and transparency to the digital out of home advertising marketplace. This is in addition to providing advertisers with data-rich reporting and advanced targeting options that enable brands to effectively reach their target audiences, which results in lower cost per thousand rates and higher than average click-through rates. It also allows brands to leverage digital signage for better customer service.

The company recently began trading on the NASDAQ, with a Benchmark Investments Inc. division; Kingswood Capital Markets, acting as the sole book-running manager for the offering. Despite its shares sinking below the target IPO price on their first trading day after it launched, the company, which has offices in the United Kingdom, Denver and Miami, still has a lot to offer, which is beneficial to brands and organizations that use its services.

ALFI Inc. (ALF), closed Tuesday's trading session at $10.14, up 40.638%, on 49,485,773 volume with 197,840 trades. The average volume for the last 3 months is 14.667M and the stock's 52-week low/high is $2.41000008/$22.50.

Sesen Bio Inc. (SESN)

MarketBeat, StockMarketWatch, MarketClub Analysis, TradersPro, Schaeffer's, PoliticsAndMyPortfolio, TopPennyStockMovers, StreetInsider, QualityStocks, Jason Bond, InvestorPlace and BUYINS.NET reported earlier on Sesen Bio Inc. (SESN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sesen Bio Inc. (NASDAQ: SESN) (FRA: PCBK) is a late-stage pharmaceutical firm which is engaged in the designing, engineering, development and commercialization of innovative protein-based therapeutics called TFPTs, for the treatment of cancer.

Sesen Bio Inc. serves consumers in the United States and has its headquarters in Cambridge, Massachusetts. The firm was founded on February 25, 2008 by K. Dane Wittrup, Casey T. Weaver. Gregory L. Verdine. K. Christopher Garcia and Reza Dana.

Sesen Bio was known as Eleven Biotherapeutics Inc. before changing its name in May 2018. The firm is party to an agreement with Leiden University Medical Center which involves the co-development of an imaging agent.

Sesen Bio Inc.’s lead product candidate is a targeted fusion protein that is locally administered known as Vicinium and is currently undergoing phase 3 clinical trials testing for its effectiveness in treating high-risk NMIBC (non-muscle invasive bladder cancer) in Canada and in the U.S. The firm also has VB6-845d, which has been developed for use in treating different types of EpCAM-positive solid tumors; Vicinium combined with a checkpoint inhibitor developed by AstraZeneca indicated for the treatment of squamous cell carcinoma of the neck and head as well as Vicinium in tandem with Durvalumab, which is currently undergoing phase 1 clinical trials for the treatment of high risk non-muscle invasive bladder cancer.

Sesen Bio Inc. recently announced that they’d submitted their Marketing Authorization Application to the European Medicines Agency for their Vicinium candidate. The European region is among the biggest regions with regard to unmet needs for patients suffering with NMIBC. The candidate demonstrated a strong benefit profile and if approved, would be the first product approved for NMIBC treatment in more than 2 decades. The drug would also benefit NMIBC patients and could help prevent the thousands of deaths that occur annually as a result of the disease.

Sesen Bio Inc. (SESN), closed Tuesday's trading session at $1.51, up 23.7705%, on 160,159,240 volume with 205,210 trades. The average volume for the last 3 months is 11.166M and the stock's 52-week low/high is $0.699999988/$6.03999996.

RAPT Therapeutics Inc. (RAPT)

Jackpot Penny Stocks, BestDamnPennyStocks, The Siri.biz Team, PennyStockPerfection, StreetInsider, ParamountEquityResearch.com, Momentum Hunter, QualityStocks, HotShotStocks, Penny Lane Reports, ElitePennyStocks, Penny Invest, MarketClub Analysis, HotOTC, CoolPennyStocks, BullRally, MarketBeat, Real Pennies, StockMarketWatch, StockEgg, Stock Rich, Trades Of The Day, BUYINS.NET, Penny Stock Picks, PS Informant, MicrocapVoice, PS 411, OTCtipReporter, PennyStockScholar, Wise Alerts, OTC Picks, OTCReporter, Eastwind Research, Stockpalooza, PennyStockDD, Penny Stock Rumble and Schaeffer's reported earlier on RAPT Therapeutics Inc. (RAPT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

RAPT Therapeutics (NASDAQ: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, has closed its previously announced underwritten public offering.

According to the update, the offering consisted of 4,356,060 shares of RAPT’s common stock, each at a public offering price of $33.00, which includes 568,181 shares issued and sold upon full exercise of the underwriters’ option to purchase additional shares of common stock. RAPT offered all of the shares of common stock and secured approximately $143.7 million in aggregate gross proceeds. Roth Capital Partners acted as co-manager for the offering.

To view the full press release, visit https://ibn.fm/8oSH6

RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing its proprietary discovery and development engine, the company is developing highly selective small molecules designed to modulate the critical immune drivers underlying these diseases.

RAPT has discovered and advanced two unique drug candidates, FLX475 and RPT193, each targeting C-C motif chemokine receptor 4 (“CCR4”), for the treatment of cancer and inflammation, respectively. The company is also pursuing a range of targets that are in the discovery stage of development. For more information about the company, visit www.RAPT.com.

RAPT Therapeutics Inc. (RAPT), closed Tuesday's trading session at $32.12, up 4.083%, on 102,977 volume with 2,048 trades. The average volume for the last 3 months is 983,041 and the stock's 52-week low/high is $14.6300001/$43.2599983.

The QualityStocks Company Corner

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced a $10 million stock buy-back program, as well as a one-time special dividend of approximately $0.23 per share. According to the update, the company will be issuing preferred shares to shareholders of SRAX common stock on Sept. 20, 2021. The preferred shares will hold approximately $6.5 million worth of Sequire clients’ stock and, as the shares are sold, the proceeds will be distributed to the preferred shareholders. “We’re excited to reward our shareholders with this dividend,” said Christopher Miglino, founder and CEO of SRAX. “We think there’s an opportunity to begin buying back shares of SRAX and we’re in the right financial position to do so.” To view the full press release, visit https://ibn.fm/r6MZ6

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Tuesday's trading session at $4.23, up 9.8701%, on 2,189,369 volume with 10,670 trades. The average volume for the last 3 months is 445,269 and the stock's 52-week low/high is $2.05999994/$7.28999996.

Recent News

Vivos Therapeutics Inc. (NASDAQ: VVOS)

The QualityStocks Daily Newsletter would like to spotlight Vivos Therapeutics Inc. (NASDAQ: VVOS).

  • According to a new study, people who spend less time watching TV and are physically active face a diminished risk of suffering from obstructive sleep apnea. This is the first research to examine sedentary lifestyles as well as physical activity with respect to the risk of developing obstructive sleep apnea. For individuals who have been diagnosed with OSA, a number of remedies exist. For example, Vivos Therapeutics Inc. (NASDAQ: VVOS) is quickly establishing itself as a worldwide leader on matters of treating mild as well as moderate forms of obstructive sleep apnea.
  • Vivos Therapeutics, Inc . (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (OSA), today announced a more detailed summary of the national study results announced by the Company on July 13, 2021, is now available on the Company’s website at: https://vivoslife.com/investor-relations/ 

Headquartered in Denver, Colorado, Vivos Therapeutics Inc. (NASDAQ: VVOS) is an emerging global leader in the treatment of mild-to-moderate obstructive sleep apnea (OSA), a debilitating condition affecting nearly 1 billion people worldwide. The company utilizes proprietary, ground-breaking technology, a proven go-to-market strategy, and a powerful executive team dedicated to changing the face of health care by helping people of all ages properly breathe and sleep.

At the core of Vivos’ mission to rid the world of mild-to-moderate OSA is the Vivos System®, a revolutionary clinical breakthrough in the treatment of mild-to-moderate sleep apnea often caused by craniofacial anatomy development. The Vivos System® multidisciplinary treatment protocol involves collaboration between physicians, specially-trained dentists who have completed advanced training in craniofacial sleep medicine, and other ancillary health care providers.

In support of its growth strategy, Vivos has established contract manufacturing facilities in the U.S., Canada and Asia.

Market & Technology Overview

Craniofacial developmental deficiencies, such as underdeveloped upper and lower jaws, are among the leading causes of OSA. According to a 2019 analysis from researchers at the University of California, San Diego, an estimated 81 million adults in North and South America suffer from moderate to severe OSA. The United States has the highest amount of these patients, with approximately 54 million adults affected, according to the report.

Registered with the FDA as a Specification Developer, Vivos develops and markets a number of oral appliances. Its technology represents the first non-surgical, non-invasive and cost-effective treatment for the estimated hundreds of millions of people globally who suffer from mild-to-moderate OSA.

Vivos integrates its specially designed, customized appliances into a patient-specific, multi-disciplinary clinical protocol, giving trained dental and medical providers the tools and roadmap needed to address certain craniofacial conditions that studies have shown to be associated with sleep-disordered breathing—including mild-to-moderate OSA.

The system’s treatment protocol involves collaboration between physicians, specially trained dentists who have received advanced training in craniofacial sleep medicine, and additional health care providers. Vivos-trained clinicians can be found in almost every major city in the U.S. and in many countries throughout the world. The company’s oral appliances have shown to be effective in over 15,000 patients successfully treated worldwide by approximately 1,200 trained dentists.

A New Paradigm in Sleep Medicine

Vivos’ proprietary system poses the potential to be the biggest breakthrough in the treatment of mild-to-moderate OSA since CPAP.

The Vivos System has been specifically designed to promote the proper growth and development of the hard and soft tissues surrounding and comprising the oral cavity, nasal cavity, upper and lower jaws, and other tissues which together form and shape the upper airway. As these areas develop more fully using the Vivos System, a patient’s airway typically widens and expands, enabling them to breathe properly through their nose. With a more open and less obstructed airway, and easier nocturnal breathing, the symptoms of SDB tend to diminish over time, and patients often report they no longer suffer from the adverse effects of SDB or OSA.

Use of the Vivos System is variable and case dependent, but typically recommended to be worn daily for 12 to 16 hours starting in the early evening and continuing overnight. The total treatment time typically ranges from 12 to 24 months, with 18 months being the approximate mean treatment time.

Biomimetic Oral Appliance

Vivos Therapeutics believes that the Vivos System technology represents the first non-surgical, non-invasive and cost-effective treatment for people with mild-to-moderate OSA.

Combining technologies and protocols that can alter the size, shape and position of the tissues of a patient’s upper airway, the Vivos System opens airway space and can significantly reduce symptoms and conditions associated with mild-to-moderate OSA.

The Vivos System treatment is typically less than $10,000 and is often reimbursable by medical insurance as an out-of-network benefit.

A potentially serious medical problem with an alternative treatment therapy available in the dental office.

Hard and soft tissues of the craniofacial complex can be non-surgically enhanced using the proprietary Vivos® System devices and clinical protocols.

Leadership

R. Kirk Huntsman – CEO, Director
With experience in strategic development, technology acquisition and product planning, key talent recruitment, and target market prioritization, Huntsman brings a broad vision paired with leadership and strategic planning skills. He has significant start-up experience in a diverse range of market sectors, including medical devices, dental management, dental practice valuations and transitions, multi-location retail, financial and capital formation, consulting, outsourced services, imports and exports (China), medical services, and software and technology.

Dr. Dave Singh – Founder, Director
A doctor three times over in dental medicine, craniofacial development, and orthodontics, Dr. Singh was educated primarily in England and has lectured in North America, Europe, Asia, and Africa. The Global Summits Institute recently named Dr. Singh as one of the Top 100 Doctors in Dentistry.

Vivos Therapeutics Inc. (NASDAQ: VVOS), closed Tuesday's trading session at $3.365, up 16.8403%, on 1,301,406 volume with 4,669 trades. The average volume for the last 3 months is 341,188 and the stock's 52-week low/high is $2.60999989/$14.4099998.

Recent News

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF)

The QualityStocks Daily Newsletter would like to spotlight Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF).

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive procedures, today announced that the final design of its i/Blue Imaging System(TM) is on target to be demonstrated at the American Urology Association (“AUA”) Annual Meeting in September. In its 116th year, the AUA Annual Meeting is the largest gathering of urologists in the world, providing education and access to groundbreaking research, new guidelines and the latest advances in medicine for urologists and urologic health care professionals worldwide. Anticipating the ideal opportunity to address its target market, Imagin has scheduled private meetings with leading urologists to demonstrate the advanced capabilities of the i/Blue Imaging System in visualizing bladder cancer. “We are very excited about the AUA Annual Meeting this year and the opportunity to introduce the final design of the i/Blue System to additional urologists,” said Jim Hutchens, Imagin’s president and CEO. “We believe the i/Blue System will lead to more widespread availability of blue light cystoscopy and answer emerging patient demand for superior bladder cancer treatment. We will also be meeting with our scientific advisory board and continuing to build relationships with other leading urologists.” To view the full press release, visit https://ibn.fm/YcQvL

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) is a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive procedures. Its initial focus is on bladder cancer.

The company’s first product is the i/Blue Imaging™ System, based on advanced optics and light sensors and employing patented ultrasensitive imaging technology. Imagin Medical believes the system can significantly improve surgeons’ ability to visualize and remove cancer cells.

Founded in 2016 and headquartered in Boston, Massachusetts, the company works to enhance its market potential by expanding its technology to multiple endoscopic indications, such as laparoscopic, colorectal and thoracic procedures, accommodating multiple contrast agents and illumination sources.

i/Blue Imaging™ System

The conventional method used for visualizing bladder cancer during surgery is an endoscopic procedure called a cystoscopy. This procedure uses white light to illuminate the bladder. White light has been used for decades and is the standard for more than 90% of the market. Blue light cystoscopy uses blue-filtered white light, which addresses the limitations of white light (such as detecting flat tumors and the fine edges that may result in cancerous cells being left behind during removal).

Blue light uses a contrast agent that causes cancer cells to fluoresce when illuminated. Surgeons are then able to more effectively visualize and resect the margins of bladder tumors to reduce the risk of recurrence. Notably, the use of the white light is still necessary during a blue-light procedure so that the surgeon can orient their position within the bladder.

Imagin Medical’s i/Blue Imaging System addresses the limitations of both white and blue light cystoscopies. The i/Blue System combines the white and blue light with an FDA-approved imaging agent and simultaneously displays side-by-side images in real-time, without the necessity to switch back and forth between the two images.

The i/Blue Imaging System is unlike other methods available on the market today. It is external to the body and can attach to almost any endoscope model currently in use. This way, hospitals adopting Imagin Medical’s technology have the ability to use their current endoscopes without the need to purchase new equipment.

Bladder Cancer Prevalence

The company’s initial focus is bladder cancer, which is the sixth most prevalent form of cancer in the United States. In 2020, the number of new bladder cancer cases is expected to total 81,400, accounting for 4.5 percent of all new cancers diagnosed. The death rate in 2020 for cancer deaths associated with the bladder is forecast at 17,980, or 3% of all cancer-related deaths (https://ibn.fm/qLi3l).

Bladder cancer also has one of the highest recurrence rates among all forms of cancer, leaving about 600,000 people in fear that their cancer will return, according to Imagin Medical. The company is committed to addressing this issue, and i/Blue demonstrations have indicated that the use of both white and blue light can enhance accuracy of detection and removal of cancer cells, potentially lowering recurrence rates.

Based on Verified Market Research, the global bladder cancer research market was valued at $3.43 billion in 2018. It is estimated to grow with a CAGR of 4.03% through 2026, resulting in a projected $4.71 billion market (https://ibn.fm/rI7G6).

Management Team

E. James Hutchens is the Chief Executive Officer of Imagin Medical Inc. He is a proven entrepreneur with over 30 years of experience in management in the medical technology industry. Hutchens served as a managing partner with Origin Partners, a $55 million early-stage venture capital fund. He was also the founder and CEO of both Microsurge Inc. (a venture-backed minimally invasive surgical company) and Choice Therapeutics (an advanced wound-care company). He is a former member of the Board of Directors of the Brigham and Women’s and Faulkner hospitals. Hutchins holds a BS in Business Administration from Boston University.

John Vacha is the company’s Chief Financial Officer. He has 20 years of experience in the health care industry. Prior to Medtronic’s acquisition of Intact Medical Corp. in 2017, Vacha was the company’s President, CEO and a board member for seven years. He is a licensed CPA in Massachusetts. Vacha has an MBA and an MS in Accounting from Northeastern University in Boston. He is also a serving member of the Board of Directors at the South Boston Health Center. He currently has two patents in electrosurgical instrumentation.

Michael G. Vergano is the Director of Operations of Imagin Medical. He has been the President of The Harvest Group Inc. since 1998, where he has provided consultant services for startups and major corporations. Vergano has over 30 years of experience in the medical device industry. He has held management positions at Microsurge Inc., Ciba Corning Diagnostics and Boston Scientific Corp. He is currently the holder of 11 medical device patents and holds a BS in Mechanical Engineering from Tufts University.

Pam Papineau is the company’s Director of Regulatory Affairs. She has over 30 years of experience in quality and regulatory affairs with Boston Scientific, Baxter and Cogentix. She has served as a consultant on various devices including imaging, endoscopy, orthopedic, GI/GU and cardiovascular applications. Papineau has successfully prepared dozens of FDA pre-market and EU submissions to support CE marking of a broad spectrum of medical devices. She is an ASQ Certified Quality Engineer, a Certified Biomedical Auditor, a Certified Quality Auditor and an ISO 13485:2016 Lead Auditor, and she is certified by the Regulatory Affairs Professional Society – U.S., EU and Canada. Papineau works with the company’s legal counsel to prepare pre-submission meetings with the FDA and activities through the regulatory approval process.

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF), closed Tuesday's trading session at $0.36, up 2.0119%, on 63,400 volume with 18 trades. The average volume for the last 3 months is 5,155 and the stock's 52-week low/high is $0.200000002/$1.16999995.

Recent News

First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF)

The QualityStocks Daily Newsletter would like to spotlight First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF).

First Energy Metals (CSE: FE) (OTCQB: FEMFF), a publicly traded Canadian mineral exploration company, today announced results of drill hole LC21-05 at its Augustus Lithium Property in Quebec, Canada. According to the update, highlights of LC21-05 include a four-meter-wide zone with 1.47% lithium oxide (“Li2O”) at 11.5 meters (“m”) depth and a three-meter-wide zone with 0.56% Li2O at 32m depth, including a one-meter-wide zone with 1.14% Li2O at 33m depth. The drill program is based on historical exploration data and the company's in-progress surface trenching and sampling program. Several historical drill hole collars were also located on the property, which helped in the location and orientation of drill holes for the current program. The samples were processed using best practices and delivered to Activation Laboratories (“ACTLABS”), Ancaster, Ontario, for sample preparation and analyses using Ultratrace 7 and sodium peroxide fusion (“Na2O2”) as summarized in the update. ACTLABS is an independent commercial, accredited ISO Certified Laboratory. To view the full press release, visit https://ibn.fm/gvxcX

First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF) is a publicly traded Canadian mineral exploration company. Its primary focus is on developing a multi-commodity mineral property portfolio by identifying, acquiring and exploring North American mineral prospects in the precious metal, base metal and industrial metals sectors.

Headquartered in Vancouver, the company (formerly known as “Agave Silver”) was first incorporated on October 12, 1966.

Core Properties – Augustus Lithium and Titan Gold

Located in Landrienne & Lacorne-Townships, Quebec, Canada, in an active lithium exploration/mining area, the Augustus Lithium Property and surrounding claims total 14,367.71 hectares . It is equipped with excellent infrastructure support, including a road network, railway, electricity, water and trained manpower available locally.

Other highlights of the Augustus Lithium Property include:

  • Geologically similar to Sayona Mining’s Authier Lithium project and Mine Quebec Lithium project located 6-12 km away.
  • Documented historical drilling over 10,000m in 62 drill holes, worth over $2 million in present day exploration expenditures.
  • Two prominent lithium and one silver prospects located on the property.
  • A potential high grade lithium resource target of 4 million tonnes at 1% lithium oxide (Li2O).
  • Potential for large volume low grade bulk tonnage near surface.
  • Two phase exploration work program includes: data compilation, geological mapping, trenching and sampling in Phase 1 (estimated cost $191,418) and diamond drilling, metallurgical testing and resource estimation in Phase 2 (estimated cost $1,166,963).

The Titan Gold Property is located in the Detour-Fenlon Greenstone Belt of east-central Quebec and is comprised of 80 mining claims totaling 4,334 hectares.

Other highlights of the Titan Gold Property include:

  • The Detour-Fenlon Greenstone Belt is host to the Detour Mine containing 20 million ounces of gold. The Fenlon Project of Wallbridge Mining has also reported strong high-grade gold intercepts and a successful high-grade (18.49 g/t Au) bulk sample.
  • Hosted within a structurally active geological environment with several northwest trending deformation zones which are splays off the Sunday Lake Deformation Zone – all key ingredients to the gold mineralization in the area.
  • The property has seen little historical exploration yet sits within what is becoming a prolific recognized gold camp.

Non-Core Properties – Kokanee Creek Gold and Scramble Mine Properties

The Kokanee Creek Gold Property consists of three mineral claims covering approximately 1,590.29 hectares in the Nelson Mining Division in British Columbia.

Other highlights of the Kokanee Creek Gold Property include:

  • Gold mineralization indicated in surface samples from historical work since 1979.
  • Subsurface gold mineralization discovered in drill holes.
  • Continuity of mineralized zones indicated through geological mapping, geochemical and geophysical survey.
  • Past producing mines in the vicinity, including the Molly Gibson and the Alpine deposits.
  • Historical production reported for the Molly Gibson Mine from 1909-1940 was at an average grade of 36.1 g/t Au and 15.3 g/t silver, with recent exploration returning samples running up to 270 g/t Au.
  • Revived exploration on the Alpine deposit area has reported a 2018 inferred resource of 142,000 oz at 16.52 g/t Au using a cut-off grade of 5.0 g/t.

First Energy Metals also holds an option to acquire a 100% interest in the Scramble Mine Gold property, located approximately 8 km east of the town of Kenora in Northwestern Ontario. The mine was discovered in 1894 but remained essentially dormant until 1984, when Boise Cascade Canada Ltd. commenced an evaluation of the property. Since 1984, approximately 5,200 meters of diamond drilling, 250 meters of surface stripping with sampling and 450 meters of underground development have taken place at the property.

Other highlights of the Scramble Mine Property uncovered as part of the company’s 2020 prospecting and sampling programs include:

  • Average value of gold in surface samples is 29.34 grams per tonne (1.03 ounces per tonne).
  • Gold assays ranged from 5.03 grams per tonne (0.18 oz/t) to 82.30 grams per tonne (2.90 oz/t), with two samples assayed over 2 oz/t.
  • All samples assayed over 5 grams per tonne gold.

Market Outlook

The global precious metals market was valued at $193.3 billion in 2020 and is expected to grow at a CAGR of 9%, resulting in a market valuation of $362.1 billion by 2027 (https://ibn.fm/WvN9Z).

The global lithium metal market was valued at $534.6 million in 2020. Through 2027, it is expected to grow at a CAGR of 9.6%, resulting in a forecast valuation of $926.6 million (https://ibn.fm/xBXcx).

First Energy Metals is well positioned to leverage growth opportunities in these expanding sectors through exploration of both its core and non-core properties.

Management Team

Gurminder Sangha is the Chief Executive Officer and Director of First Energy Metals Ltd. He is experienced in the financial industry, focusing on providing advisory-level services to privately and publicly traded companies. Mr. Sangha brings over 18 years of diverse experience related to financial management, business leadership and corporate strategy to his role with First Energy Metals. During his tenure as a board member for various publicly traded companies, he has led initiatives related to corporate finance, business development and corporate governance. Mr. Sangha has an MBA from both Queens University and Cornell University.

Jurgen Wolf is the Chief Financial Officer and Corporate Secretary for First Energy Metals Ltd. He has been involved in the oil and gas industries for over 15 years, assisting public companies with administration and investor relations. Mr. Wolf was educated in Germany and immigrated to Canada in 1953. From 1958 to 1982, he owned and operated pre-cast concrete factories in Calgary and Vancouver. From 1982 to 2002, Mr. Wolf owned and operated J.A. Wolf Projects Ltd., a commercial construction company. He is the previous President and Director of the former US Oil and Gas Resources Inc., which amalgamated to form Petrichor Energy Inc. in 2005. Mr. Wolf retains director roles with several public companies.

First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF), closed Tuesday's trading session at $0.2174, up 8.7%, on 15,550 volume with 10 trades. The average volume for the last 3 months is 7,569 and the stock's 52-week low/high is $0.086999997/$0.45719999.

Recent News

DSG Global Inc. (OTCQB: DSGT)

The QualityStocks Daily Newsletter would like to spotlight DSG Global Inc. (DSGT).

DSG Global (OTCQB: DSGT)an emerging player in the electric vehicle (“EV”) segment with a large lineup of affordable and diverse vehicles, has reported its financial report for the quarter ended June 30, 2021; the report was highlighted by the announcement of 299% revenue growth for the company compared to the same period last year. The company reported second-quarter sales of $494,838 compared to $123,955 for Q2 2020, an increase of $370,883 or 299%. The company attributed much of the growth to new installations of its Infinity, Tag and Text GPS system. In addition to the increased sales, the company noted that is working to fufill upcoming contracts during Q3. To view the full press release, visit https://ibn.fm/fFHis

DSG Global Inc. (OTCQB: DSGT) is an emerging global technology company with interconnecting businesses in fast growing market sectors. With roots in the golf industry, the company specializes in golf fleet management and is moving quickly into road-ready electric vehicles for delivery in the third quarter of 2021.

In 2019, the company secured exclusive North America distribution rights for Jonway Automobile Co. road-ready electric vehicles (EVs). Jonway, based in Zhejiang, China, began manufacturing new vehicles s in 2003 and today produces Electric powered Cars, Trucks, Vans, SUV’s, and Scooters. Jonway vehicles are exported to more than 80 countries and are built to comply with U.S. safety and environmental standards.

These vehicles are being sold via DSG’s wholly owned subsidiary, Imperium Motor Company (IMC). The move into consumer vehicles capitalizes on the company’s strength in the selection and distribution of EVs, the ability to work with large manufacturers and in application of proprietary technology unique to DSG. DSG’s advanced fleet tracking can be integrated into Jonway EVs to offer a customized scalable and integrated solution to meet the needs of small businesses and large enterprises.

The Future is Electric

With decades of EV experience in golf, including distribution of highly advanced carts, DSG recognized the huge chasm between consumer interest in acquiring road ready EVs versus current EV models’ lack of availability and affordability. As such, the company focused on becoming a distribution and EV brand management company unencumbered by the manufacturing process. The manufacturers take responsibility for building vehicles to DSG’s specifications and fulfillment of regulatory and licensing requirements.

DSG has also established a distribution agreement with Skywell New Energy Automobile Group Ltd., an Asian-based EV manufacturer. Skywell will supply DSG with SUV’s, Passenger Vans, Cargo Vans, Commercial Vehicles and Buses that will be fully certified for use in the United States.

Brands

Imperium Motor Company (IMC) seeks to transform the way the world drives by making greener transportation available to everyone. IMC is an EV sales and marketing company that distributes directly to consumers and through third party distributors, offering a wide variety of affordable vehicles equipped for the North American market. The company’s emphasis is on great design, a green mindset, performance and functionality. Its vehicles include 26 models of high-speed, mid-speed and low-speed electric vehicles including cars, trucks, SUVs, vans, buses and scooters.

Vantage Tag Systems (VTS) is a global leader in the design, manufacture, and marketing of fleet management solutions for the golf industry. VTS has developed the TAG suite of products that represents the industry’s first completely modular fleet management solution. The company’s patented analytics, mobile touch screen GPS units and electric golf carts are sold around the world through a network of established distributors and partnerships with notable brands in fleet and equipment manufacture. VTS solutions also have applications in managing commercial, agricultural, military and government fleets. VTS is a wholly owned subsidiary of DSG Global.

Market Outlook

The global EV market was valued at $273 billion in 2017, according to Fortune Business Insights, and is projected to exceed $987 billion by 2027, with a projected CAGR of 17.4 percent. The relative high manufacturing costs of EVs compared to gasoline-powered vehicles and the resulting higher sticker price to consumers are major obstacles to near term market adoption.

The global e-bike market is estimated to grow to $70 billion by 2027 from its current valuation of $41.1 billion. An estimated 130 million e-bikes are expected to be sold globally over the next two years. The U.S. imported approximately 600,000 e-bikes in 2020, according to the Light Electric Vehicle Association, and its analysts expect that number will grow substantially in 2021.

Management Team

Robert “Bob” Silzer is the CEO of DSG Global. He is a serial entrepreneur who turns technology ideas in high growth industries into profitable businesses. With roots in the golf industry, he founded Vantage Tag Systems in 2008. Vantage Tag Systems is now a DSG subsidiary specializing in GPS-enabled fleet management.

Zahir Loaiza is the interim CFO of DSG Global. She assumed the role in March 2021, after having previously served as the company’s Corporate Controller. Her diverse international experience includes working at a publicly traded mining company, several law firms and more in the U.S., Canada and South America. Prior to pursuing a career in corporate finance, she was the owner of two retail entities.

Rick Curtis is the president and COO of Imperium Motor Company, the automotive subsidiary of DSG Global. His 40-year background in the automotive industry includes manufacturing, vehicle distribution, parts distribution, service management, dealer development and executive management of dealer groups. Prior to joining Imperium, Mr. Curtis served as president of Mullen Technologies and grew the company into a world class provider of electric vehicles, battery technology and energy storage systems.

William “Bill” Rex is president of Imperium Motor’s EV Bus and Motor Home Division. He has more than 40 years’ experience at suppliers of buses/electric buses, motor homes, trucks, specialty vehicles and batteries. He is the founder of Rexhall Industries Inc., formerly a publicly traded manufacturer of RVs and distributor of buses and coaches. He previously served as president of THOR West, a subsidiary of THOR Industries that manufactures shuttle buses, and as president of BYD Coach and Bus.

Patrick J. Parenti is the SVP Global Sales at DSG subsidiary Vantage Tag Systems. He has nearly 30 years of experience in golf and golf course management. Prior to joining DSG in 2012, Mr. Parenti served for 10 years as SVP at ProLink Systems, a leading global provider of GPS golf-course management systems.

Clint Singer is Director of Engineering at Vantage Tag Systems. He has been a senior developer in the golf industry for more than 20 years and has an extensive background in GPS systems.

Daniel Price is Technical Operations Manager of DSG Global’s European Region, UK, South Africa. In addition to his background in mechanical and electronic engineering, he is an audio engineer, specializing in automotive audio and security. He has also worked with high end electronic security companies in the UK and previously owned an electronic security and CCTV company.

Steven Mueller is Operations Manager at Vantage Tag Systems. He worked in the global pulp and paper market for nine years, facilitating the global movement of thousands of tons of timber products annually. Additionally, he has a successful decades-long track record of managing operations and consulting for a wide range of retail businesses.

DSG Global Inc. (DSGT), closed Tuesday's trading session at $0.1795, up 4.3483%, on 180,157 volume with 57 trades. The average volume for the last 3 months is 706,104 and the stock's 52-week low/high is $0.0108/$1.51999998.

Recent News

InnerScope Hearing Technologies Inc. (OTC: INND)

The QualityStocks Daily Newsletter would like to spotlight InnerScope Hearing Technologies Inc. (INND).

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, today announced that its CEO Matthew Moore has been invited to present at two separate investor conferences on Wednesday, Aug. 18, 2021. According to the update, Moore will be hosting the live online presentations and answering questions from the investment community and existing shareholders. Moore’s presentations will highlight InnerScope’s positioning within the newly emerging market driven by upcoming deregulation of the hearing aid sector, which allows over-the-counter hearing aids to be sold in retail stores and pharmacies. Moore’s Aug. 18 presentations will begin at 1 p.m. ET at the Emerging Growth Conference and 3 p.m. ET at the SNN Network Summer Virtual Event 2021. To view the full press release, visit https://ibn.fm/LGRNf

InnerScope Hearing Technologies Inc. (OTC: INND) is a Nevada corporation incorporated on June 15, 2012, with its principal place of business in Roseville, California. The company was initially started in 2006 – operating as InnerScope Advertising Agency Inc. – to provide advertising and marketing services to retail establishments in the hearing device industry. On August 25, 2017, the company changed its name to InnerScope Hearing Technologies Inc. to better reflect its current direction as a hearing health technology company that manufactures, develops, distributes and sells numerous innovative hearing health-related products, hearing treatments and hearing solutions, direct-to-consumer (DTC) through a scalable business model.

The company is a manufacturer and a distributor/retailer of DTC, FDA (U.S. Food and Drug Administration) registered, Bluetooth app-controlled hearing aids and personal sound amplifier products (PSAPs), hearing-related treatment therapies, doctor-formulated dietary hearing supplements, proprietary CDB oil for treating tinnitus and assorted hearing and health-related products targeting approximately 70 million Americans suffering from hearing-related problems. The company’s mission is to improve the quality of life of the 70 million people in North America and the 1.5 billion people worldwide who suffer from hearing impairment and/or hearing-related issues.

The management team of InnerScope is applying decades of industry experience and believes it is well-positioned, with its innovative in-store point-of-sale Free Self-Check Hearing Screening Kiosks (“Hearing Kiosks”), to directly benefit when the Over the Counter (OTC) Hearing Aid Act (the “OTC Hearing Aid Law”) is enacted (expected in late 2021 based on the President’s Executive Order issued on July 9, 2021) The OTC Hearing Aid Law allows OTC hearing aids for perceived mild-to-moderate hearing losses to be sold in retail stores without having to see a professional. InnerScope’s Hearing Kiosk is designed to help the tens of millions of Americans with undetected/untreated mild-to-moderate hearing loss treat themselves with the company’s easy, convenient and affordable OTC hearing aids, in-store and/or online.

Industry Game-Changer – New Emerging Market with 48 Million Potential Customers

The following is sourced from The White House Fact Sheet detailing an Executive Order from President Biden aimed at saving Americans with hearing loss thousands of dollars by allowing hearing aids to be sold over the counter at drug stores:

“Hearing Aids: Hearing aids are so expensive that only 14% of the approximately 48 million Americans with hearing loss use them. On average, they cost more than $5,000 per pair, and those costs are often not covered by health insurance. A major driver of the expense is that consumers must get them from a doctor or a specialist, even though experts agree that medical evaluation is not necessary. Rather, this requirement serves only as red tape and a barrier to more companies selling hearing aids. The four largest hearing aid manufacturers now control 84% of the market.”

On July 9, 2021, President Biden noted the following in reference to his Executive Order relating to hearing aids:

“Right now, if you need a hearing aid, you can’t just walk into a pharmacy and pick one up over the counter. You have to get it from a doctor or a specialist. Not only does that make getting hearing aids inconvenient, it makes them considerably more expensive, and it makes it harder for new companies to compete, innovate and sell hearing aids at lower prices.”

“As a result, a pair of hearing aids can cost thousands of dollars. That’s a big reason why just one in seven Americans with hearing loss actually use a hearing aid.”

InnerScope Game-Changers

For InnerScope, this Executive Order could present a significant opportunity. The company is uniquely positioned with a number of strategic advantages and offerings in the space, including:

  • First to Market: Free self-check hearing screening kiosks deployed in national pharmacy chains, big-box retailers & national and local groceries chains
  • Online Hearing Screening Tests: For national retailers to use their websites to attract more customers in conjunction with the company’s in-store hearing kiosks
  • The HearIQ App for iOS and Android users: Offers a free self-check hearing test and provides a user control function for InnerScope’s Bluetooth app-controlled self-adjusting rechargeable hearing devices
  • Customer Monthly Subscription Model: Offering the lowest, most affordable monthly payment options (as low as $42 per month for pair of rechargeable, app-controlled hearing aids) for consumers to purchase hearing aids and receive free upgrades every two years.

The In-Store Hearing Screening Kiosks and Online Free Hearing Screening Tests

Innerscope’s hearing screening kiosk and online hearing screening tests offer free self-check hearing evaluation using the world’s first “Hearing Triage” artificial intelligent pattern recognition software, which has a unique ability to classify both level (degree of loss) and pattern (type of loss). In addition, the software can detect the probable location of the hearing problem and its degree of severity.

The tests are developed as a hearing wellness tool to help track hearing ability and (if tests results indicate a hearing loss) make recommendations for in-store point of sale or online purchase of one of InnerScope’s hearing devices, as well as providing recommendations to see one of the professionals in InnerScope’s local contracted network of hearing health care experts for further follow-up testing if necessary. The software also generates an audiometric report which is instantly emailed to the customer.

The HearIQ App

InnerScope is the creator of the HearIQ App, which offers free self-check hearing tests and provides a user control function for InnerScope’s line of Bluetooth app-controlled self-adjusting rechargeable hearing devices. InnerScope developed the free hearing test part of the HearIQ App to help with the early detection of hearing loss for the 1.5 billion people worldwide who have untreated hearing loss or some form of hearing issues that may be undetected and do not have access to a computer for InnerScope’s online hearing screening test.

Hearing Aid Products

Through its dedicated online store, MyHearIQ.com, InnerScope offers affordable, direct-to-consumer, Bluetooth app-controlled, self-adjusting hearing technology to empower consumers to take control of their hearing care. InnerScope’s hearing technology allows the customer in less than 10 minutes using any smartphone to personalize each hearing device to their hearing needs using an onboard in-ear custom-fit self-testing feature through the HearIQ App.

InnerScope is shifting hearing health care from traditional brick-and-mortar hearing care clinics to customers’ homes by providing a unique solution to give customers top quality, affordable access to hearing aids without the need to see a hearing professional or go to a hearing care clinic. As a result, InnerScope can deliver the same level and quality of hearing technology and expert support for the customer from their homes at a fraction of the cost of traditional channels. All InnerScope hearing aid devices are medical-grade and available with professional remote programming and support services from one of the company’s licensed hearing professionals through the HearIQ App.

Hearing & Tinnitus Dietary Supplements

InnerScope has developed a proprietary line of doctor-designed hearing & tinnitus dietary supplements to help people with hearing problems protect themselves from future hearing issues. There are currently three types of formulas to choose from, including Ear-Ring Relief for the 60 million Americans who suffer from tinnitus, HearingVite + Memory Boost for people with hearing loss and cognitive issues, and HearingVite + Multivitamin for maintaining proper hearing health and levels of nutrients.

Complete Line of Hearing Health Care Products

InnerScope offers a brand label of assorted ear care and hearing aid maintenance products. In support of overall ear health and ensuring maximum performance from its hearing aids and comfort for its customers, InnerScope provides a whole line of care items, including cleaning kits, wipes, spray and drying tablets, ear cleaner for wax removal, a natural lubricant agent for new hearing aids and hydrating lubricating ear gel.

Verified Wholesale and Direct-to-Consumer Sales

InnerScope is a verified wholesaler with Walmart for premium affordable direct-to-consumer hearing aids, personal sound amplification and hearing health accessories. InnerScope also created an easy shopping experience for its hearing and tinnitus vitamins through Walmart and Amazon Prime. With new partnerships in the works, the company aims to add other online and brick-and-mortar establishments to its vitamin distribution network in the future.

Hearing Aid Market Outlook

The global hearing aid market is expected to reach $11.02 billion by 2028, growing at a CAGR of 7.4% during the forecast period. This marks a significant increase from the $6.47 billion value reported in 2020, an increase largely driven by innovations being made in hearing aid technology (https://ibn.fm/bRWUb).

As a leading wholesale provider and direct-to-consumer business, InnerScope is positioned to disrupt the global hearing aid market. Its partnerships with some of the United States’ largest retail distributors and wholesalers are only strengthening the company’s position within the industry.

Management Team

Matthew Moore is the President and CEO of InnerScope Hearing Technologies Inc. He grew up in the hearing health industry, working alongside his grandfather through internships and mentorships. At the age of 10 years old, he became Chief Marketing Officer and Chief Operating Officer of his parent’s private hearing aid practice, the largest in Northern California and the second largest in the state. Matthew has shown his leadership ability by creating distribution partnerships with big industry names and independent retailers/pharmacies.

Kim Moore is the Chief Financial Officer of InnerScope Hearing Technologies Inc. She has worked in the hearing aid industry for over 45 years, helping her father maintain his hearing aid practice in Central Valley, California. She began working on marketing with her father at the age of eight, learning that no customer walks through the door without proper advertising and marketing. As a licensed hearing instrument specialist, Kim has given hearing tests to more than 30,000 people.

Mark Moore is the Chairman and Co-Founder of InnerScope Hearing Technologies Inc. He has over 35 years of experience in hearing aid dispensing, practice management, private label brand management and hearing aid marketing. He has personally fit hearing aids to over 10,000 hearing-impaired people. In addition, he has been responsible for developing and testing proven new industry marketing and advertising methods and best practice strategies, which has made him one of the most sought-after experts in the hearing aid industry. Mark was previously a columnist for Advanced for Audiologists, a global industry publication, and served on the American Academy of Audiology (AAA) advisory board for AudiologyNow conventions. He has also developed patented and patent-pending nutritional supplements for hearing-related issues, aural rehabilitation programs and low-level laser therapy for tinnitus and sensorineural hearing loss.

InnerScope Hearing Technologies Inc. (INND), closed Tuesday's trading session at $0.01105, up 13.9175%, on 54,772,348 volume with 872 trades. The average volume for the last 3 months is 57.073M and the stock's 52-week low/high is $0.000000999/$0.097999997.

Recent News

Sugarmade, Inc. (OTC: SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (OTC: SGMD).

Sugarmade (OTC: SGMD), an emerging leader in the vertically integrated cannabis marketplace based in California, has closed on its previously announced acquisition of a Los Angelese property; the company noted that the property has been designated as a new distribution and delivery hub for SGMD’s Nug Avenue cannabis delivery segment. The company has also previously announced the signing of a memorandum of understanding to apply and obtain three non-storefront California cannabis licenses from the Los Angeles Department of Cannabis Regulation; the company is also applying for corresponding licenses from the California Bureau of Cannabis Control. These licenses should provide the licensing foundation for the opening of three new cannabis-related commercial operations in California. To view the full press release, visit https://ibn.fm/090jQ

Sugarmade, Inc. (OTC: SGMD) is a product and brand marketing company investing in operations and technologies with disruptive potential. The company is focused on collaborating with real people in real-time to identify the emerging desires and behaviors poised to unlock new opportunities and pathways for growth. Sugarmade seeks to redefine the marketplace by nurturing an innovative and compelling relationship between brand, botany and business – resulting in both undeniable consumer value and an intriguing cross-pollination of revenue sources.

The company’s core strategic plan is centered on expanding its end-market access as a central player in the growing California cannabis delivery marketplace while developing its in-house cannabis production capacity to verticalize operations in the space. Through a combination of organic growth and strategic acquisitions, Sugarmade intends to develop a full farm-to-door vertically integrated cannabis business.

Brand Portfolio

Sugarmade has investments in a number of subsidiaries with active operations in the California cannabis sector. These include:

  • NUG Avenue – Sugarmade owns a 70% stake in NUG Avenue, a cannabis delivery service based in Southern California providing hand-selected top-shelf products from Stiiizy, Kanha, PlugPlay and more.
  • BudCars – Sugarmade is an investor in cannabis delivery service of BudCars’ first operating location in Sacramento, California. BudCars is an online-shopping experience designed to provide new customers with an easy way to discover and order cannabis products within minutes.

Acquisition of Lemon Glow Company

On May 17, 2021, Sugarmade took a major step toward closing the loop on what its management team believes to be one of the most promising vertically integrated cannabis models in the thriving California market when it announced the signing of a definitive agreement for its acquisition of Lemon Glow Company Inc.

The Lemon Glow acquisition includes 640 acres of property, 32 of which have already been designated for outdoor cannabis cultivation. Per the company’s news release, the annual potential cultivation yield at the property is estimated to be approximately 4,000 pounds of dry trimmed cannabis flower per acre per year, which represents approximately 128,000 pounds, or 64 tons, of dry trimmed cannabis flower per year in total.

Notably, Sugarmade also benefits from the acquisition in terms of team capital, as Lemon Glow executive team members will stay on and become the core management team at the cannabis cultivation site, granting the operation over 30 years of cannabis cultivation experience.

“The Lemon Glow team are tremendous additions to the Sugarmade team,” Jimmy Chan, CEO of Sugarmade, commented in announcing the definitive agreement. “They have vast experience and established skills, as well as intricate knowledge of the property and its local grow context. That’s an enormous added value proposition in this deal. We look forward to bringing them on board, ramping up operations at the property, and taking key steps toward delivering on the promise of Sugarmade’s farm-to-door vision.”

Market Opportunity

The California cannabis industry has continued to record tremendous growth since voters approved a measure to legalize recreational use of the plant in 2016. According to data from MJBizDaily, California’s legal market hit $4.4 billion in sales in 2020, up from $2.8 billion in 2019 and $1.4 billion in 2018.

Those figures highlight California’s status as the largest legal cannabis market in the world. With roughly 28 million residents over the age of 21, California is more than twice the combined size of the four states (Arizona, New Jersey, Montana and North Dakota) that legalized cannabis in 2020.

The COVID-19 pandemic was a key driver in the growth of cannabis delivery services throughout the state in 2020. One California cannabis delivery firm reported a 60% increase in new delivery customer sign-ups in the 30 days following the March 13, 2020, declaration of a national emergency. As a result of this boom, tech companies in cannabis ecommerce were able to dramatically increase their market share.
Sugarmade’s continued efforts to develop a farm-to-door vertically integrated cannabis business position it to capitalize on these trends as the California cannabis industry continues to expand moving forward.

Management

Jimmy Chan is the CEO of Sugarmade. He is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Sugarmade, Inc. (OTC: SGMD), closed Tuesday's trading session at $0.0021, up 5%, on 30,465,276 volume with 212 trades. The average volume for the last 3 months is 114.23M and the stock's 52-week low/high is $0.000699999/$0.019999999.

Recent News

Mobius Interactive Ltd.

The QualityStocks Daily Newsletter would like to spotlight Mobius Interactive Ltd..

  • Mobius Interactive will be promoting Serie A football matches in Brazil with the Mobius.bet brand on GLOBO TV BRAZIL 
  • Each match will feature at least one of the Big 6 Teams in Italian football: Udinese vs. Juventus; Sampdoria vs. AC Milan; Hellas Verona vs. Inter Milan; Genoa vs. Napoli; and U.S. Salernitana 1919 vs. AS Roma
  • Brazil is the largest gaming market in Latin America. The industry is experiencing unprecedented growth; Mobius Interactive is uniquely-positioned to take full advantage of this major expansion

Mobius Interactive, an international online gaming operator, has announced that its flagship brand Mobius.bet will be sponsoring Italy Serie A football games in Brazil in August on GLOBO TV in BrazilSerie A TIM is a professional league competition for football clubs at the top of the Italian football league. Lega Serie A was created for the 2010-2011 season and is regarded as one of the best football leagues in the world. 

Mobius Interactive Ltd. is an online gaming operator launching in September 2020 with a variety of unique offerings catering to diverse demographic groups. In partnership with Ultra Play, a leading eSports and iGaming platform, Mobius Interactive is seeking to attract a network of high-net-worth gamers from around the world through the use of loyalty and gamification programs designed to enhance customer engagement by leveraging state-of-the-art customer relationship management systems and joint-ventures with over 600 VIP and Master gaming affiliates.

Array of Brands

Mobius Interactive is seeking to target a variety of customer segments and geographies through its diverse brand offerings, including:

  • Aragon Casino: Austria, Finland, the Balkans, Canada, Africa and New Zealand
    Catering to consumers aged 21 to 45, Aragon Casino brands itself along the lines of medieval fantasy, mimicking elements from the likes of The Walking Dead and Game of Thrones.
  • Club Double: Austria, India, Brazil, Finland, Canada, Africa and New Zealand
    Targeting the 30 to 65 age demographic, Club Double is designed to exude a classic yet magical old Hollywood and vintage Miami & Las Vegas air.
  • MobiusBet: Germany, Austria, Switzerland, Brazil, Latin America, New Zealand and India
    MobiusBet is designed to appeal to the 18- to 38-year-old eSports community, bringing together loyalty programs, targeted gamification and product merchandising in one seamless package.

Key Differentiating Indicators

Mobius Interactive has designed its platform with a number of key differentiation traits relative to its target market. These include:

  • The use of affiliates: Mobius Interactive has partnered with over 600 VIP and Master gaming affiliates, who will introduce high-value players to the company’s award-winning iGaming platform. Mobius added over 150 proven affiliates in Europe, Brazil, Finland and New Zealand over a period of just 20 days.
  • eSports Focus: Mobius.Bet, Mobius Interactive’s dedicated eSports hub, will cater to the quickly growing eSports segment, which is expected to rise to a value of $1.7 billion in 2021. With Mobius’ COO being one of the original founders of the eSports.com brand, the company aims to capitalize on this growing segment of the gaming industry.
  • Customer Relationship Management (CRM): Mobius has partnered with Solitics, a new and real-time CRM system, enabling the company to personalize customers’ gaming experiences in an interactive and highly intelligent manner.
  • Loyalty & Gamification: Mobius Interactive is set to introduce a unique loyalty and gamification program designed to increase customer engagement from signup. Loyalty and gamification programs have been proven to increase daily active wagering volumes by 30% while simultaneously increasing daily player activity by 60%. Furthermore, the introduction of these programs can help lower the company’s customer acquisition costs while adding a differentiating element to its platform.

Partnership with Puurl

Puurl provides a solution that embeds eGaming platforms into any existing online e-commerce store. First, shoppers can install the Puurl add-on to their browsers. Then, when visiting their preferred e-commerce stores, players will be prompted to bet, with the potential to win the products they’re browsing. The Puurl solution enables e-commerce operators and eGaming platforms to earn additional gambling revenues – even when their players are shopping. Through its partnership with Puurl, Mobius Interactive will look to add a unique revenue stream to complement its core business operations.

Management Team

Lynn Pearce, CEO, is an experienced, data-driven, commercially focused, strategic brand marketer with over 15 years of proven success in the global gaming industry, from land-based casinos in the UK to online gaming companies offering sports betting, poker and casino games. She was head-hunted to join a startup in Prague that launched 26 casinos, becoming profitable within the first three months of operation, before she relocated to Malta to join a leading B2B casino software development company as head of marketing, where she led global marketing, PR, product development, branding and go-to-market campaigns, retaining full control of a six-month budget of €1 million to increase brand awareness and customer engagement. She recently returned to the B2C side of gaming to launch three new brands in Germany, Brazil and India. She writes articles regularly for Infinity Gaming Magazine and has been a judge for the prestigious International Gaming Awards, a significant event for the gaming industry held each year prior to the largest gaming exhibition of the year, ICE London.

Robin Lawson, Vice President & COO, has been involved in iGaming for over 10 years, successfully founding two VIP casino departments across international locations in Latin America, as well as startup company Tabella in Europe. He most recently co-founded and acted as COO for eSports.com, which raised over $5.5 million as a startup ICO and was sold to German media giant ProSieben. Lawson is also a senior iGaming consultant for startup casino groups and an advisor to blockchain-based tech groups. His long-time experience and proven track record in startup organizations demonstrate his operational leadership skills.

Nicholas de Freitas, Vice President, Marketing, is one of the pioneers of digital stills photography for major retail companies in Africa and Australia. He left to start up UrbanActive, an outsourcing agency, working as marketing project manager and implementing major retail projects. He received his certification in digital marketing from the University of Stellenbosch. He has worked over the past few years as the marketing manager for various poker rooms and casinos, liaising and building relationships with software developers, successfully implementing a number of casino and poker products and holding regular weekly report sessions with the heads of all divisions of the company, spanning South Africa, Canada, Malta, Norway and Costa Rica.

Gary Eldridge, Chairman, is an experienced entrepreneur with a history of working in the venture capital and private equity industry. He is skilled in capital markets, M&A and funding startups and is a strong business development professional. For the past 30 years, he has created and managed numerous public and private companies in Canada, the U.S., Amsterdam, London, Zurich, Dusseldorf, Singapore and Panama. In addition to holding the role of chairman of the company, Eldridge is acting as a mentor to the team, assisting with the financials and structure of the company while allowing the team to be fully focused on Mobius’ growth and operations.

Recent News

chart

Save Foods Inc. (NASDAQ: SVFD)

The QualityStocks Daily Newsletter would like to spotlight Save Foods Inc. (NASDAQ: SVFD).

Save Foods (NASDAQ: SVFD), an agri-food-tech company focused on developing and selling eco-friendly products specifically designed to extend shelf life and ensure food safety, today announced its appointment of Dr. Art Dawson as chairman of its advisory board. According to the update, the newly formed advisory board will focus on building market awareness and facilitating sales of Save Foods’ produce treatment solutions. Dr. Dawson has extensive experience across the post-harvest sector and currently serves as the founder and president of the Dawson Company, an agriculture and post-harvest consultancy. “We are delighted to welcome Art as chair of our advisory board. He will be a tremendous asset to our team,” said Save Foods Inc.’s CEO David Palach. “Art has repeatedly demonstrated his ability to guide products from development to market and propel revenue growth in the global arena. I am confident we will benefit greatly from his insight and expertise as we turn our focus from product development to commercialization.” To view the full press release, visit https://ibn.fm/5MEUb

Save Foods Inc. (NASDAQ: SVFD) is an agri-food tech company focused on developing and selling eco-friendly products specifically designed to ensure food safety and extend the shelf life of fresh fruits and vegetables. The company is focused on addressing two of the most significant challenges faced by the industry: (1) food waste and loss, and (2) food safety.

Fungi like mold and yeast, as well as foodborne pathogens, are typically responsible for fresh produce spoilage and foodborne illness. Save Foods’ integrated solutions improve safety, freshness and quality every step of the way, from field to fork. The company’s natural products control human and plant pathogens, allowing growers, packers and food retailers to reduce waste and boost revenues. More food ends up on consumers’ plates, and less ends up in landfills.

Save Foods’ products use all-natural ingredients to protect fresh produce from microbial spoilage and pathogens with zero toxicity. The company’s treatments leave no harmful residues on produce or in the environment and maintain product freshness over time. Fresh produce treated with Save Foods’ products can already be found in supermarket chains across the U.S. and Europe. Those chains have reported that the company’s products are reducing fruit spoilage by 50% on average at the retail level. With no need for additional steps in the treatment process nor special equipment, Save Foods’ products are easy to implement and come in versatile applications suitable for the different stakeholders along the food supply chain.

Initial applications for the company’s offerings include post-harvest treatments in fruit and vegetable packing houses that process citrus, avocados, pears, bell peppers and mangos. By controlling and preventing pathogen contamination and significantly reducing the use of chemicals and their residues, Save Foods’ products not only prolong shelf life; they also ensure safe, natural and healthy food. Save Foods has the first green products that could realistically replace the different chemicals used today in food treatment while controlling waste and food safety.

Products & Technology

  • SavePROTECT or PeroStar, a processing aid added to fruit and vegetable wash water and used in post-harvest treatment;
  • SF3HS and SF3H, post-harvest treartment solutions to control both plant and foodborne pathogens;
  • SpuDefender, for controlling post-harvest potato sprouts; and
  • FreshPROTECT, for controlling spoilage microorganisms on post-harvest citrus.

Save Foods’ products are based on a proprietary blend of food acids which have a synergistic effect when combined with certain types of sanitizers and fungicides at low concentrations in a non-organic setting. The combination eliminates fungicide residues or reduces them to levels below the established Maximum Residue Levels (MRLs). The company’s fruit and vegetable wash is odorless and does not irritate human eyes, skin or airways. Save Foods’ blend does not leave any residues of toxicological concern on the treated surface of produce, and all its ingredients are classified by the U.S. Food and Drug Administration (FDA) as Generally Recognized As Safe (GRAS). There are 7 patent families related to Save Foods’ technology.

Applications

The company’s products have been commercially validated on citrus, mangos, avocados, pears, bell peppers, microgreens and various fresh cut vegetables. Save Foods is in the validation process for bananas, apples, figs, berries, lettuce, papayas and more. The company is also validating the efficacy of its products for pre-harvest treatment, starting with citrus trees.

Market Outlook

The world population is expected to grow to almost 10 billion by 2050, boosting current agricultural demand by some 50%. Providing healthy and safe food for the world’s population is one of the biggest challenges of the 21st century.

Globally, around 664 million tons of fresh fruits and vegetables are lost every year from field to fork, wasted by spoilage, and almost one in 10 people globally falls ill every year from eating contaminated food, with an estimated resulting cost around $90 billion.

Disposing of all that wasted food requires additional expense and harms the environment with resulting greenhouse gas emissions. The post-harvest food treatment market was valued at $1.5 billion in 2019 and is expected to grow to $2.3 billion by 2026, achieving a CAGR of 6.5%.

Management Team

David Palach is CEO of Save Foods. He spent over a decade with Intel Israel, where his last position was Manager of Business Development for Israel and Europe. Prior to that, he served as a controller of two of Intel’s largest factories in Israel, where he supervised a budget of over $1 billion. He also served as the CEO of B-Pure Corporation Ltd., a management and maintenance company involved in protecting and improving the environment. During his tenure, he helped turn around several struggling subsidiaries and made them profitable.

Vered Raz Avayo is the company’s CFO. Before joining SaveFoods in 2018, she spent more than 10 years as CFO at LGC, the Leviev Group of Companies. She has operated her own financial and business consultancy and has served as a director for a number of public companies in Israel.

Dan Sztybel is CEO of SaveFoods Ltd., the Israeli subsidiary of Save Foods Inc. He previously led the Life Sciences Advisory at EY Israel and early on recognized the potential of Israel as a center of innovation in the digital health space. He has been an adviser on digital health strategy to large pharmaceutical companies and is a cofounder of MyndYou, a digital health start-up focusing on cognitive impairment. He is also a co-founder of the DigitalHealth.il conference, the largest digital health conference in Israel.

Dr. Neta Matis is Vice President of R&D at Save Foods Ltd the Israeli subsidiary of Save Foods Inc . She holds a Ph.D. in organic chemistry and an MBA from Tel Aviv University. Prior to joining Save Foods in 2019, she held multiple research chemist and product development roles at Verdia Inc. and its parent company, Helsinki-based Stora Enso Oyj.

Nimrod Ben Yehuda is the founder and CTO of Save Foods Ltd. He was previously the CEO/CTO of Swissteril Water Purifications Ltd. He has also been CEO at Nir Ecology Ltd., and was Joint-CEO at NitroJet Ltd.

Dr. Art Dawson is the U.S. Business Manager for SaveFoods Inc. He has been president of The Dawson Company, which focuses on creating sales opportunities for new agricultural technologies, previously Dr. Dawson held senior industry positions like General Manager Worldwide of the Decco , the Post Harvest Division for Elf Atochem. He holds a Ph.D. in Plant Physiology from UC Riverside and is licensed in California as an agricultural Pest Control Advisor.

Save Foods Inc. (SVFD), closed Tuesday's trading session at $7.74, off by 1.4025%, on 1,871 volume with 24 trades. The average volume for the last 3 months is 9,501 and the stock's 52-week low/high is $1.75/$30.1000003.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX).

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is featured in a report issued by PCG Digital Holdings LLC, an affiliate of PCG Advisory Inc. In the report, PCG noted that “Lexaria, delivering active ingredients to patients, could deliver for investors too.” The report stated that LEXX may be poised for a surge as the company’s DehydraTECH(TM) platform has proven to be an effective way to deliver active ingredients. The release noted that DehydraTECH had shown effectiveness as a hypertension treatment using CBD as well as with various antivirals. To view the full press release, visit https://ibn.fm/yBxoy

Lexaria Bioscience Corp. (NASDAQ: LEXX) (CSE: LXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 19 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has a collaborative research agreement with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has filed for patent protection for specific delivery of nicotine, vitamins, NSAIDs, testosterone, estrogen, cannabinoids, terpenes, PDE5 inhibitors (with brand names like Viagra), tobacco and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Tuesday's trading session at $5.39, off by 3.2316%, on 90,054 volume with 762 trades. The average volume for the last 3 months is 1.102M and the stock's 52-week low/high is $3.97510004/$12.50.

Recent News

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)

The QualityStocks Daily Newsletter would like to spotlight Energy Fuels Inc. (UUUU).

  • Energy Fuels (NYSE American: UUUU) (TSX: EFR) and Neo Performance Materials (TSX: NEO) recently announced that the first container of mixed rare earth (“RE”) carbonate was shipped from UUUU’s White Mesa Mill in Utah to NEO’s rare earth separation facility in Estonia. This shipment marked an important milestone toward restoring the critical U.S. and European rare earth supply chains. Chemours (NYSE: CC), based in Georgia, mines natural monazite that contains both the rare earth elements and naturally occurring uranium. “The rare earth elements are then processed into RE carbonate by UUUU’s White Mesa Mill before being shipped off to Estonia and separated into rare earth oxides and other value-added rare earth compounds,” a recent article reads. “This commercial-scale process has established Energy Fuels as the only company in North America that currently produces a monazite-derived, enhanced rare earth material, and the shipment of the product represents the beginning of a new, environmentally responsible rare earth supply chain.” To view the full article, visit https://ibn.fm/eC3Ao.
  • Mining is the extraction of geological materials and valuable minerals out of the ground, with the most popular mining methods being open surface, underground and in-situ mining. Unlike the other mining methods mentioned, in-situ mining doesn’t involve a lot of digging or landscape disturbance. Also known as in-situ leaching and in-situ recovery, the method isn’t a new innovation in the natural resources industry, having been used for more than five decades to mine uranium. Nearly 50% of the total uranium mined globally is mined using in-situ recovery. Other minerals that can be extracted from the earth using this method include copper, silver and sometimes, gold. Apart from being environmentally friendly, the mining method also creates a safer environment for mine workers and lowers operating and capital costs. These are major benefits that any mining company should aim for if the site conditions are right. This is exactly what Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) is doing at its Nichols Ranch project in Wyoming and its Alta Mensa project in Texas.

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR),based in Lakewood, Colorado, is the country’s largest producer of uranium and the leading conventional producer of vanadium, both designated by the U.S. government as critical minerals.

As the leading U.S. diversified uranium miner, Energy Fuels’ uranium production portfolio stands apart in the world. Energy Fuels has more uranium production facilities, more production capacity, and more in-ground resources than any other company in the United States. In fact, the company’s assets have produced over one-third of all U.S. uranium over the past 15 years and is uniquely positioned to increase production to meet new demand.

Energy Fuels utilizes both conventional and in-situ recovery (“ISR”) technology to produce uranium from three strategic facilities:

  • White Mesa Mill in Utah (conventional) has a licensed capacity of over 8 million pounds of U3O8 per year. The highly strategic White Mesa Mill is the only conventional uranium mill in the country and is proximate to some of the largest and highest-grade uranium mines and projects in the U.S., including the Company’s Canyon mine, La Sal Complex, Henry Mountains Complex and Roca Honda Project. White Mesa Mill provides Energy Fuels with significant production scalability as uranium demand increases. The White Mesa Mill also has other diverse businesses, including vanadium, rare earth elements (REE’s), alternate feed materials recycling and land cleanup, all described below.
  • Nichols Ranch Plant (ISR) is located in the productive Powder River Basin district of Wyoming and has a total licensed capacity of 2 million pounds of U3O8 per year. Nichols Ranch has produced 1.2 million pounds of U3O8 since commissioning in 2014, and it has significant future expansion potential from 34 fully licensed wellfields containing significant in-ground uranium resources.
  • Alta Mesa Plant (ISR) is located on over 200,000 acres of private land in Texas. The fully licensed and constructed ISR project has a total operating capacity of 1.5 million pounds of uranium per year and produced nearly 5 million pounds of U3O8 between 2005 and 2013. This low-cost production facility is currently on standby, maintained in a state of readiness to respond to expected increases in demand.

In addition to being the largest uranium miner in the U.S., Energy Fuels’ overall portfolio also includes a pipeline of high-quality, large-scale exploration and development projects that are permitted or are in advanced stages of permitting, as well as an industry-leading U.S. NI 43-101 Mineral Resource portfolio.

FACTOID: Energy Fuels has led industry efforts over the past two-plus years to get the U.S. government to recognize the importance of domestically produced uranium, including the 2018 – 2019 Uranium Section 232, the ongoing Nuclear Fuel Working Group and the recently announced creation of the U.S. strategic uranium reserve. The U.S. is by far the largest consumer of uranium in the world, yet we import almost all of our requirements; Energy Fuels aims to change that.

Nuclear Market Potential

Multiple studies in top scientific journals have shown that nuclear power is cleanest and most economical way to produce reliable electricity as worldwide demand continues to soar. Nuclear power is presently the only available and affordable low-carbon power source that can meet both current and future baseload electricity demands while simultaneously reducing air pollution and mitigating climate change. U.S. nuclear power plants currently generate nearly 20% of the nation’s electricity overall and 55% of its carbon‐free electricity and even a modest increase in electricity demand would require significant new nuclear capacity by 2025. According to the World Nuclear Association (WNA), there are currently 441 operable reactors, with another 54 units under construction and 439 in various stages of planning; in addition, the WNA has identified a potentially massive supply/demand gap through 2040 of 1 billion pounds. These factors among others are expected to significantly drive increased demand for uranium.

Reasons Nuclear is Gaining Traction

  • Nuclear reactors emit no greenhouse gases during operation. Over their full lifetimes, they result in comparable emissions to renewable forms of energy such as wind and solar.
  • Unlike any other form of energy, the waste from nuclear energy is contained and managed securely. Used fuel is currently being safely stored for ultimate disposal or future reprocessing, and 96% of this waste can potentially be recycled.
  • Greater demand for clean electricity to power everything from homes to automobiles, reducing dependence on fossil fuels.

No. 1 U.S. Producer of Vanadium in 2019

Energy Fuels also produces vanadium as a byproduct of uranium production. Vanadium is designated a critical mineral, essential to the economic and national security of the United States. Energy Fuels was the largest producer of vanadium in the U.S. in 2019, and has significant high-grade, in-ground vanadium resources, as well as a separate high-purity vanadium production circuit at their White Mesa Mill, which is also the only conventional vanadium mill in the country. Crucial for use in the steel, aerospace, and chemical industries, vanadium plays a critical role in the production of high-strength and light-weight metallic alloys and demand is expected to increase across the globe.

Energy Fuels has several fully permitted and developed standby mines containing large quantities of high-grade vanadium, along with uranium, including:

  • La Sal Complex (Utah)
  • Whirlwind Mine (Colorado/Utah)
  • Rim Mine (Colorado)

Vanadium has also gained increased attention as a catalyst in next-generation high-capacity, “community-scale” batteries used for energy storage generated from renewable sources. Demand is only expected to grow as this market expands. With recent upgrades in its vanadium production operations, in 2019 Energy Fuels produced commercial levels of the highest purity (99.7%) vanadium in the mill’s history and can rapidly adjust production to meet volatile market conditions. Energy Fuels is one of the very few known avenues that provides investors access the vanadium market.

Rare Earth Element (REE) Production, Alternate Feed Material Recycling, and Land Cleanup

The White Mesa Mill also provides the company with diverse cashflow generating opportunities. Security of supply for Rare Earth Elements (REEs) supporting U.S. military and defense requirements is a major issue today. Energy Fuels has been approached by a number of entities, including the U.S. government, inquiring about the potential to process certain REEs at the mill. The White Mesa Mill is currently licensed to process certain REEs, including tantalum and niobium. And, early indications are that the mill can be utilized to produce several other REEs. The White Mesa Mill is also the only facility in North America licensed and capable of recycling alternate feed materials (AFMs). AFMs are essentially low-level waste materials that contain recoverable quantities of natural (or unenriched) uranium. The Company typically generates between $5 and $15 million per year from AFM recycling. Finally, Energy Fuels is seeking to become involved in the cleanup of legacy Cold War era uranium mines in the Four Corners region of the U.S., including on the Navajo Nation. The U.S. Environmental Protection Agency (EPA) has access to over $1.5 billion for the cleanup of just a fraction of the sites on the Navajo Nation. The White Mesa Mill is fully licensed to receive much of this material, we are one of the government’s lowest cost options, and we have the ability to recycle the material and produce usable uranium from it.

Management Team

Mark S. Chalmers, President and CEO
Mark S. Chalmers is the president and chief executive officer of Energy Fuels, a position he has held since Feb. 1, 2018, following his role as chief operating officer of Energy Fuels from July 1, 2016 – Jan. 31, 2018. From 2011 to 2015, Chalmers served as executive general manager of Production for Paladin Energy Ltd., a uranium producer with assets in Australia and Africa, including the Langer Heinrich and Kayelekera mines where, as head of operations, he oversaw sustained, significant increases in production while reducing operating costs. He also possesses extensive experience in in situ recovery (“ISR”) uranium production, including management of the Beverley Uranium Mine owned by General Atomics (Australia), and the Highland mine owned by Cameco Corporation (USA). Chalmers has also consulted to several of the largest players in the uranium supply sector, including BHP Billiton, Rio Tinto, and Marubeni, and until recently served as the chair of the Australian Uranium Council, a position he held for 10 years. Chalmers is a registered professional engineer and holds a Bachelor of Science in Mining Engineering from the University of Arizona.

W. Paul Goranson, COO
W. Paul Goranson is the chief operating officer for Energy Fuels. Goranson has 30 years of mining, processing and regulatory experience in the uranium extraction industry that includes both conventional and in-situ recovery (“ISR”) mining, and he is a registered professional engineer. Prior to the acquisition by Energy Fuels of Uranerz Energy Corporation, Goranson served as president, chief operating officer and director for Uranerz, where he was responsible for operations of the Nichols Ranch ISR Uranium Project. In addition to those duties, he also managed uranium marketing, regulatory and government affairs, exploration and land. Prior to joining Uranerz, Goranson served as president of Cameco Resources, where he led the operations at the Smith Ranch-Highland, Crow Butte and North Butte ISR uranium recovery facilities. Goranson also served as vice president of Mesteña Uranium LLC, and he has served in senior positions with Rio Algom Mining, (a subsidiary of BHP Billiton), and Uranium Resource Inc. Goranson has a Bachelor of Science in Natural Gas Engineering from Texas A&I University, and a Master of Science in Environmental Engineering from Texas A&M University-Kingsville.

David C. Frydenlund, CFO, General Counsel, Corporate Secretary
David C. Frydenlund is chief financial officer, general counsel, and corporate secretary of Energy Fuels. His responsibilities include oversight of all legal matters relating to the company’s activities. His expertise extends to NRC, EPA, state and federal regulatory and environmental laws and regulations. From 1997 to 2012, Frydenlund was vice president of regulatory affairs, general counsel and corporate secretary of Denison Mines Corp., and its predecessor International Uranium Corporation (“IUC”). He also served as a director of IUC from 1997 to 2006 and CFO of IUC from 2000 to 2005. From 1996 to 1997, Frydenlund was vice president of the Lundin Group of international public mining and oil and gas companies, and prior thereto was a partner with the Vancouver law firm of Ladner Downs (now Borden Ladner Gervais) where his practice focused on corporate, securities and international mining transactions law. Frydenlund holds a bachelor’s degree in business and economics from Simon Fraser University, a master’s degree in economics and finance from the University of Chicago and a law degree from the University of Toronto.

Curtis H. Moore, Vice President of Marketing and Corporate Development
Curtis H. Moore is the vice president of Marketing and Corporate Development for Energy Fuels. He oversees product marketing for Energy Fuels, and is closely involved in mergers & acquisitions, investor relations, public relations, and corporate legal. He has been with Energy Fuels for over 12 years, holding various roles of increasing responsibility. Prior to joining Energy Fuels, Moore worked in multi-family real estate development, government relations and public affairs, production homebuilding, and private law practice. Moore is a licensed attorney in the State of Colorado. He holds Juris Doctor and MBA degrees from the University of Colorado at Boulder, and a Bachelor of Arts dual degree in Economics-Government from Claremont McKenna College in Claremont, California.

Energy Fuels Inc. (UUUU), closed Tuesday's trading session at $4.67, off by 2.0964%, on 2,170,384 volume with 9,581 trades. The average volume for the last 3 months is 2.883M and the stock's 52-week low/high is $1.41999995/$7.82999992.

Recent News

AmpliTech Group Inc. (NASDAQ: AMPG)

The QualityStocks Daily Newsletter would like to spotlight AmpliTech Group Inc. (AMPG).

AmpliTech Group (NASDAQ: AMPG), a designer, developer and manufacturer of state-of-the-art communications components for satellite communications, space, telecom (5G and 6G) and defense markets, today announced its financial numbers for the second quarter as well as the first six months of 2021; the company also provided a growth outlook. Second-quarter highlights included an increase of revenue from $660,699 in Q2 2020 to $1,024,410, an increase of 55% over Q2 last year and a 117% increase over last quarter; an order backlog of $2.45 million in contractual hardware and engineering services anticipated for delivery over the next three to six months; and a secured follow-on Low Noise Amplifier (“LNA”) order from a Fortune 500 global defense and aerospace company with shipment expected next quarter and secured $500,000 in orders in July for custom LNAs; those shipments are also expected to go out in the third quarter. To view the full press release, visit https://ibn.fm/4k0Rr

AmpliTech Group Inc. (NASDAQ: AMPG) (NASDAQ: AMPGW) designs, develops and manufactures custom radio frequency (RF) components for the commercial, SATCOM, space and military markets. In addition to developing new products for the 5G/6G wireless ecosystem and infrastructure, the company has placed focus on the development of leading-edge solutions in quantum computing in support of U.S. efforts to reach the coveted position of quantum supremacy. The company maintains a commitment to R&D that allows it to remain at the forefront of emerging technologies. AmpliTech aims to use its advanced techniques and IP to provide tomorrow’s technology today, improving everyone’s quality of life.

AmpliTech was founded by Fawad Maqbool in 2002 to fill the need for affordable, high-quality, customized and state-of-the-art amplifiers and components. Headquartered in Bohemia, New York, the company currently has distributors and representatives available worldwide.

Product Portfolio

AmpliTech’s mission is to develop quality, state-of-the-art microwave amplifiers by leveraging its experience, proven technical expertise and superior design heritage. The company’s products cover a frequency range from 50 kHz to 44 GHz, with plans to eventually offer designs up to 100 GHz. Its current catalog includes:

Amplifiers

Passive Components

All the company’s products come with a satisfaction guarantee, as the company is fully committed to providing only high-quality products free from manufacturing and material defects and guaranteed to perform according to applicable specifications.

Consulting Services

Leveraging more than 100 years of combined experience in microwave systems and component design ranging from active components to passive devices, AmpliTech also provides valuable consulting services and technical assistance to its customers.

With capabilities ranging from initial design to final manufacturing and delivery, the company’s team also offers project management services and advice on both technical aspects and how to handle business issues such as resource allocation, customer contact, budget restraints, time limits and more.

Other key benefits of AmpliTech consulting services that can give its customers a definitive edge include:

  • Timely technical assistance
  • Little or no learning curve
  • Less long-term costs associated with full-time employees with benefits and salaries
  • Availability when necessary
  • Customer support with schedules, project management and on the job training
  • Access to technology
  • Partnering for manufacturing and/or complete turn-key product solution
  • Personal guidance from concept to development
  • Custom designs for each application

Market Outlook

The global microwave devices market was valued at $7.44 billion in 2019 and is expected to grow at a CAGR of 3.23% and reach $9 billion by 2025 (https://nnw.fm/zqMEk). Governmental expenditures in the defense and space communications sectors are expected to expand the opportunities for growth within the industry.

AmpliTech continues to follow its strategy of identifying key elements in today’s technological revolution. It is leveraging its technical expertise and experience to align product portfolios and IP with innovation (https://nnw.fm/rVzxX). The company has plans to be a catalyst in the enhancement, development and distribution of breakthroughs in the following sizeable markets:

  • High Speed Terrestrial and Satellite Terminals (SATCOM, “Internet in the Sky”)
  • 5G/Wi-Fi6E and 6G wireless infrastructure (Cellular Base Stations, Small Cells, Private Wi-Fi Networks)
  • IoT (Internet of Things)
  • Cloud Farms, Big Data and MEC architecture
  • Quantum Supercomputers/Quantum Research
  • Deep Space Astronomy
  • Autonomous Self-Driving Vehicles
  • Telemedicine, AR/VR (Augmented and Virtual Reality)
  • Drones, UAVs (Unmanned Aerial Vehicles)
  • Cyber-security
  • Military/Defense ECM/EW

Management Team

Fawad Maqbool is the Founder, President, CEO and CTO of AmpliTech Group Inc. He has been in the microwave industry for over 30 years. Mr. Maqbool spent 14 years developing state-of-the-art amplifiers and components for MITEQ Inc., a leading microwave and communications equipment supplier. He founded AmpliComm in 2000, which was subsequently acquired by Aeroflex Inc. Mr. Maqbool has management and design experience, which has led to the development of microwave technology on a commercial and military level. He holds a B.S.E.E in Microwave Engineering and a B.S.E.E in Bio-Medical Engineering from CUNY and an M.S.E.E from the Polytechnic University of New York.

Louisa Sanfratello is the company’s CFO. She is a Certified Public Accountant (CPA) and has worked in various industries since 1998. During this time, she held roles as an accountant for charities and schools, consisting of the preparation of official financial documents and day-to-day financial management requirements. Ms. Sanfratello began her professional career in 1987 at Holtz, Rubinstein & Co., a public accounting firm. She gathered two years of experience there before gaining her CPA and taking on more challenging roles.

Brandon Worster is the company’s Director of Engineering. He joined AmpliTech at the end of 2019, bringing over 14 years of design and management experience. His specialty is Low Noise and Medium Power Amplifiers, but Mr. Worster also has vast experience with various systems, including RF/Microwave devices and systems. He holds a master’s degree in electrical engineering and is an adjunct professor at Farmingdale University in New York.

John P. Pastore is AmpliTech’s Director of Sales. He has worked in the microwave industry for more than 35 years, including time with some of the industry’s leading names. Mr. Pastore is a hands-on professional who has experience that spans over 20 years with progressive roles that blend technical, manufacturing, customer service and management expertise. He is an extremely valuable asset to the company as it moves forward due to his business savvy approach and deep industry knowledge. He has a B.S. in Business Management.

M. Syed handles Technical Sales and is the company’s Director of IT. He is an electrical engineer with more than 10 years of business experience. Since 2011, he has led Technical Sales for AmpliTech, and he recently became the President and CEO of his own company while also serving as Chief Technical Sales consultant for numerous other companies and groups in New York City. Mr. Syed has been in the IT industry for 25 years. He is a Computer Engineer by trade and a Certified Netware Engineer and Microsoft Certified Systems Engineer.

AmpliTech Group Inc. (AMPG), closed Tuesday's trading session at $3.25, off by 8.4507%, on 315,555 volume with 1,354 trades. The average volume for the last 3 months is 265,579 and the stock's 52-week low/high is $0.879999995/$19.7999992.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Wednesday's trading